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The isomerization of uridine to pseudouridine (Ψ), known as pseudouridylation, is the
most abundant post-transcriptional modification of stable RNAs. Due to technical
limitations in pseudouridine detection methods, studies on pseudouridylation have
historically focused on ribosomal RNAs, transfer RNAs, and spliceosomal small nuclear
RNAs, where Ψs play a critical role in RNA biogenesis and function. For decades, Ψ
research was confined to this small subset of cellular RNAs ,owing to limitations in
methods for Ψ detection. Interest in this modification was reinvigorated, however, with
reports that Ψ is conditionally induced in different environmental contexts and that
pseudouridylation of certain codons recoded amino acid incorporation. Pseudouridine has
thus revealed itself as a dynamic modification capable of fine-tuning RNA function.
In this thesis, I describe how I attempted to develop a high-throughput technique
to identify novel sites of pseudouridylation throughout the whole transcriptome. By
identifying what transcripts are subject to pseudouridylation, I hoped to better understand
Ψ’s functional role. While pursuing this work, a series of deep sequencing methods —
Pseudo-seq, Ψ-seq, PSI-seq, and CeU-seq — were published that mapped Ψ positions
across the entire transcriptome with single nucleotide resolution. Collectively, these
methods greatly expanded the catalogue of pseudouridylated transcripts and revealed
conditionally-dependent sites of pseudouridylation in response to cellular stress. With

four techniques available, I undertook a critical analysis of their results, uncovering a
comparatively small subset of robustly detectible putative Ψ sites. This analysis
underscored the merits and limitations of each approach.
Having identified areas for improvement in the available Ψ-detection approaches,
I adapted Ψ-seq to profile sites of pseudouridylation in the protozoan parasite
Trypanosoma brucei. My efforts at transcriptome-wide Ψ-detection, however, were
undercut by an inability to experimentally replicate Ψ-seq.
As much as this thesis documents an endeavor to better understand the functional
role of pseudouridylation, it also documents systematic and thorough experimental
failure. In so doing, the work detailed in this thesis highlights a need within the sciences
to foster increased transparency and reproducibility.
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CHAPTER 1. Introduction1
The central dogma, enunciated by Crick in 1958 and the
keystone of molecular biology ever since, is likely to prove
a considerable oversimplification.
— Anonymous, 1970

A central question in biology is how life’s great diversity and complexity results from a
genetic alphabet composed of a mere four letters: adenine (A), cytosine (C), guanine (G),
and thymine (T). Conceived in 1958 by Francis Crick, the central dogma of biology
proposes a neat linear flow of genetic information from one gene to one protein — that
DNA is transcribed into RNA that is then translated into protein. While the central dogma
is certainly a workable model, it has long been considered a crude oversimplification that
fails to recognize the plastic processes that occur beyond what is strictly encoded in the
genomic sequence. In particular, RNA is subject to a whole host of modifications — from
splicing to transcript-content modification — as it relays genomic information to the
cellular machinery. The expansive catalog of transcriptional modifications highlights that
RNA is no mere mediator of “hard-coded” genetic content, but instead plays a vital and
dynamic role in cellular function.
1.1 A primer on post-transcriptional modifications
RNA is subject to over 100 types of chemically distinct post-transcriptional modifications
that span all three phylogenetic domains — Archaea, Bacteria, and Eukarya [79]. RNA
1
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modifications were first identified in the 1950s during the early days of RNA biology,
underscoring their ubiquity in the transcriptome [26,28]. Over the last six decades,
modifications have been identified in a range of RNA species where they play a pivotal
role in refining RNA structure and function.
Transfer RNAs (tRNAs) are the most highly modified transcripts, with an average
of 17% of their total nucleotide content subject to post-transcriptional modification [57].
Although RNA modifications are not required for tRNAs to adopt their famed cloverleaf
shape, modifications allow tRNAs to adopt subtly different conformations as needed. For
instance, while dihydrouridine adds conformational flexibility where present,
pseudouridine adds rigidity. Three-dimensional nucleotide maps of Escherichia coli and
Saccharomyces cerevisiae ribosomal RNAs (rRNAs) have also revealed that the bulk of
modifications (~95% and 60%, respectively) occur in regions important for translation,
such as the A, P, and E sites of tRNA- and mRNA-binding [29]. In messenger RNAs
(mRNAs), 2ʹ-O-methylated ribonucleotides, such as N6,2ʹ-O-dimethyladenosine (m6Am),
are often found in the 5ʹ untranslated region (UTR) and mark the beginning of transcripts
[68]. Deamination modifications in mRNAs, which convert adenosine to inosine or
cytidine to uracil, can also diversify the coding sequence of target transcripts or alter their
stability when directed to the 3ʹ UTR [13,23,98,102].
Our increasing knowledge of the location of RNA modifications, like the ones
listed above, has deepened appreciation for the wide-ranging roles they play in finetuning molecular function. Once thought to be constitutive, some chemical modifications,
such as ribose methylation, have been found to be reversible, while others, such as
pseudouridylation, can be induced in response to changes in environment. The dynamic
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changes in RNA modification states are reminiscent of the DNA epigenome, and have
thus led to coinage of the terms “RNA epigenome” or the “epitranscriptome.”
1.2 Pseudouridine: the fifth ribonucleoside
The most abundant of the post-transcriptional modifications, pseudouridine (Ψ) was the
first to be discovered and is often referred to as “the fifth ribonucleoside” [26,28,79]. Ψ is
the C5-glycoside isomer of uridine that results when the N1-C1ʹ bond linking the uracil
base to the ribose sugar is broken. The base is then rotated 180º around the N3-C6 axis
and a non-canonical C5-C1ʹ glycosidic bond is formed (Figure 1.1) [21].
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Figure 1.1. Isomerization of uridine to pseudouridine.
Pseudouridylation begins with the breakage of the N1-C1ʹ bond followed by a
180° base rotation around the N3-C6 axis. The resulting Ψ contains an additional
hydrogen bond donor (red) and a C5-C1ʹ base-sugar linkage (blue).

Ψ’s designation as a fifth ribonucleoside is fitting given its unique physiochemical
properties with respect to its U isomer. Following isomerization, the Watson-Crick edge
of uridine remains unchanged, allowing for Ψ-A base pairing. Important to note, the
3

resulting Ψ has an additional hydrogen bond donor at the N1 position. In an RNA chain,
Ψ’s ability to coordinate a structural water molecule via its N1H group confers added
rigidity to RNA structure by increasing base stacking and adding extra hydrogen bonds
between the base and its phosphate backbone. Additionally, N1H-mediated water
coordination has been reported to increase Ψ/A base-pairing stability compared to the
U/A pair [90]. Ψ’s additional hydrogen bond donor has also been thought to contribute to
novel base pairing interactions in Ψ-containing RNA [21,96]. In fact, recent structural
studies demonstrate that the ribosome can accommodate non-canonical codon-anticodon
base pairing mediated by a pseudouridylated sense codon, the functional import of which
is discussed later in this chapter [37].

1.3 Site-specific pseudouridylation is catalyzed by two distinct mechanisms
Site-specific pseudouridylation is catalyzed by pseudouridine synthases (PUSs) through
one of two distinct mechanisms: a protein-only (stand-alone) mechanism and a box
H/ACA snoRNP-catalyzed (guide-dependent) mechanism [112]. Stand-alone
pseudouridylation is catalyzed by a single PUS that recognizes its particular substrate,
either through a specific consensus motif or secondary structure [14,16,78,110].
On the other hand, RNA-dependent pseudouridylation is mediated by an RNAprotein (RNP) complex, consisting of four core proteins — Nhp2p, Gar1p, Nop10p, and
the Ψ-synthase Cbf5 (Nap57/dyskerin in mammals) — assembled on a box H/ACA small
nucleolar RNA (snoRNA) scaffold. Each H/ACA snoRNA folds into a conserved
hairpin-hinge-hairpin-tail structure (Figure 1.2). Each hairpin contains a unique singlestranded internal loop — the pseudouridylation pocket — that is complementary to a
specific sequence in a substrate RNA, flanking 3-10 nucleotides on either side of a
4

particular target uridine [41,91]. The substrate RNA base pairs with the Ψ pocket,
positioning the target uridine at the base of the upper stem of the hairpin where Cbf5 then
site-specifically catalyzes pseudouridylation. Notably, the pseudouridylation pocket’s
short guide sequence is split by a hairpin structure that is variable in length, making it
difficult to computationally predict a particular H/ACA snoRNA’s target RNA for
pseudouridylation. While several stand-alone PUSs are not required for cell viability,
Cbf5 deficiency is lethal. High-throughput sequencing techniques have identified a
growing set of snoRNAs with unknown target sites, suggesting there is still much of the
Ψ landscape left to be charted [22,54,71,105,128].

pseudouridylation
pocket

pseudouridylation
pocket

Figure 1.2. Schematic of eukaryotic box H/ACA snoRNP complex.
H/ACA snoRNA forms a hairpin-hinge-hairpin tail structure, which coordinates four core
proteins: Nhp2, Nop10, Gar1, and Cbf5. The guide sequence in the pseudouridylation
pocket base pairs with the complementary substrate RNA, directing the site-specific
isomerization of the target U by the Ψ-synthase Cbf5 (figure courtesy of Yi-Tao Yu).
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1.4 Hints at the biological significance of pseudouridylation
Pseudouridine’s distinct structural properties make it unsurprising that Ψs are wellknown to cluster in evolutionarily conserved and functionally important regions of stable
noncoding RNAs (ncRNAs). Over the years, appreciation for the significant role
pseudouridylation plays in RNA function has grown. Ψ’s functional relevance has been
well-documented in rRNAs, where pseudouridylation is required for ribosome biogenesis
and translational fidelity and efficiency, and in small nuclear RNAs (snRNAs), where
specific Ψ residues have been identified as necessary for proper pre-mRNA splicing
[12,56,70,127,130]. Furthermore, many Ψs in rRNAs and snRNAs are conserved across
species, occurring at identical or near-identical sites [29,126].
1.4.1 Pseudouridylation is conditionally induced in different cellular contexts
Once thought to be a constitutive modification, pseudouridylation has been found to be
inducible in response to cellular stress and differentiation, suggesting pseudouridylation
may provide a dynamic regulatory mechanism for RNA function [11,88,125].
Following heat shock and nutrient deprivation, two novel Ψs were identified in
yeast U2 spliceosomal snRNA: Ψ56 and Ψ93 [125]. While Ψ56 conversion is catalyzed
by the stand-alone PUS Pus7, Ψ93 is targeted by the H/ACA snoRNP complex guided by
snR81 [125]. Notably, both inducible Ψs are flanked by sequences that deviate from the
canonical motifs recognized by Pus7 and snR81. For instance, the Ψ pocket of snR81 —
known to modify Ψ42 in U2 snRNA and Ψ1051 in 25S rRNA — pairs with two
mismatches to the sequence flanking Ψ93. This finding is contradictory to previously
identified constitutive RNA-dependent targets of pseudouridylation, which pair with
perfect sequence complementarity (i.e. without mismatches) to their corresponding guide

6

snoRNAs. Imperfect sequence complementarity between the guide and substrate RNAs is
therefore a likely hallmark of conditionally inducible Ψ targets. Importantly, Ψ93
interferes with pre-mRNA splicing, suggesting a role in altering gene regulation in
response to nutrient deprivation.
Developmentally dependent Ψ28 in U6 spliceosomal snRNA, which is guided by
the stand-alone PUS Pus1, has been found to initiate a filamentous growth program in
yeast, which is triggered by, for instance, nitrogen- or glucose-starved environments or
exposure to fusel alcohols [11]. Ψ28 is not present during log-phase growth and is not
induced by other standard stress conditions, such as heat-shock, indicating that this
alternate site of pseudouridylation is induced by filamentation-specific environmental
stressors. Like Ψ93 in U2 snRNA, U6-Ψ28 affects pre-mRNA splicing, this time
reducing the splicing efficiency of suboptimal introns. Altered splicing to target
transcripts may therefore activate mRNAs necessary for filamentous growth, or inactivate
those that inhibit such a growth program.
1.4.2 Pseudouridylation alters amino acid decoding
Ψ has long been known to play a role in translation of mRNAs. rRNA pseudouridylation
is essential for translation fidelity, and pseudouridylated anticodons have been shown to
alter ribosomal decoding in echinodermal mitochondrial RNA [115]. However, because
the possibility of mRNA pseudouridylation had never been closely studied, the effect of
pseudouridylation in protein-coding transcripts remained unknown. While studies on
pseudouridylation had traditionally focused on its role in tRNAs, snRNAs, and rRNAs,
largely due to their abundance, there was no reason to assume that pseudouridylation
substrates should be restricted to this class of noncoding RNAs.

7

Given that the structure of H/ACA snoRNAs is so well-conserved, guide RNAs
can theoretically be engineered to target pseudouridylation to any RNA of interest by
modifying the guide sequence in the Ψ pocket [53]. In a proof of principle experiment,
the Yu group at University of Rochester Medical Center engineered guide RNAs derived
from the naturally occurring yeast H/ACA snoRNA SNR81 to target pseudouridylation to
mRNA to investigate the effect of Ψ in protein-coding transcripts. Ψ was artificially
targeted to a premature stop codon within a reporter mRNA to monitor translation
termination efficiency. Interestingly, introducing Ψ into each of the known stop codons
(UAA, UAG, UGA) suppresses translation termination by directing the incorporation of
biochemically and structurally similar amino acids. Specifically, ΨAA and ΨAG code for
serine and threonine, while ΨGA codes for tyrosine and phenylalanine [61]. Further
studies have confirmed similar nonsense-to-sense codon conversion in bacteria,
suggesting that Ψ-mediated recoding is conserved in prokaryotes and eukaryotes [37].
Ψ’s recoding potential is strengthened by structural studies that demonstrate the
ribosome can accommodate non-canonical codon-anticodon base pairing mediated by a
pseudouridylated sense codon [37]. The crystal structure was resolved for ΨAG pairing
with the tRNASer anticodon stem loop AGI. The decoding center’s unexpected plasticity
suggests that Ψ may similarly recode sense codons, thereby expanding the genetic code
and generating protein diversity beyond what is encoded in genomic DNA. This finding
is all the more intriguing given the possibility of condition-dependent pseudouridylation
events in coding regions in response to changes in environment. In fact, ΨUU, which is
derived from the phenylalanine-encoding UUU codon, has been found to code for
cysteine and tyrosine (Yu, personal communication). While some groups have
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theoretically predicted what other pseudouridylated sense codons could be coding for,
they still agree that more experimental data are needed before more accurate predictions
can be made [96].
In vitro-transcribed mRNAs in which every U residue is pseudouridylated have
also been found to exhibit enhanced stability and translation efficiency when delivered in
vivo [62]. Important to note, however, is that fully pseudouridylated mRNAs synthesized
for this study were translated into functional proteins (i.e. GFP, lacZ, and luciferase).
While the protein products were not sequenced to determine if Ψ facilitated alternate
amino acid incorporation, the likelihood that a functional protein would result from
multiple codon recoding events is low. Consequently, the number or density of Ψs within
a particular protein-coding transcript could perhaps play a role in Ψ-mediated recoding.
1.5 Methods of pseudouridine detection
Pseudouridine was first identified as an unknown ribonucleoside in 1951 by subjecting
calf liver RNA isolates to ion-exchange chromatography [26]. Because Ψ is mass-silent
with respect to U, rather labor-intensive chromatographic techniques continued to be the
prevailing method for Ψ detection. These methods took advantage of the effect of Ψ’s
additional hydrogen bond donor on migration. As the field advanced, a combination of
RNase digestion, radiolabeling, and chromatography-based methods produced the first
pseudouridine maps in tRNAs and rRNAs [47,52,113]. Notably, these approaches
required large amounts of purified RNA as a starting material, and were thus limited to
studying only highly abundant RNA species.
In 1993, a method was developed by Bakin and Ofengand taking advantage of the
carbodiimide CMC (N-Cyclohexyl-Nʹ-(2-morpholinoethyl)carbodiimide metho-p-
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toluenesulfonate) to label Ψ residues [7]. Under physiological conditions, CMC acylates
guanosine (G) at the N1 position and uracil at the N3 position (Figure 1.3A). Notably,
isomerization to Ψ creates an additional CMC conjugation site, so CMC acylates Ψ
residues at the N1 and N3 positions. CMC adducts are susceptible to alkaline hydrolysis
(pH=10.4), except in Ψ where CMC remains specifically and irreversibly bound at the N3
position. Traditionally, the method has been coupled to primer-extension assays to map
sites of pseudouridylation, as Ψ-CMC adducts result in reverse transcriptional (RT) arrest
one base downstream of a Ψ site (Figure 1.3B). Ψ-CMC is thus detectable as a distinct
stop, whereas without conjugation to CMC, Ψs are indistinguishable from U by the
reverse transcriptional machinery. Since the CMC/RT approach was introduced, it has
become the primary means of Ψ detection.
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Figure 1.3. CMC specifically labels Ψ and causes RT arrest one base 3' to Ψ.
(A) CMC specifically labels pseudouridine. Following alkaline hydrolysis, CMC (red)
remains bound to the N3 position of Ψ. (B) Reverse transcription using a primer specific
to U2 snRNA maps Ψ-CMC-mediated RT arrest sites (right lane) when compared to
mock-treated control (left lane).
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While the CMC/RT approach is not quantitative, CMC derivatization has been
coupled to matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS)
to quantify the relative abundance of derivatized Ψ [97]. When CMC is conjugated to its
Ψ target, it can be detected as a distinct mass shift of 252 Da. A key limitation of this
method, which is discussed more in the next chapter, is its reliance on uniform
derivatization of CMC to its targets for accurate quantitation.
In more recent years, limitations inherent in CMC derivatization have
incentivized the development of CMC-independent techniques. In particular, site-specific
RNase H cleavage of a candidate Ψ site was combined with splinted ligation,
ribonuclease digestion, and thin layer chromatography to identify hypothesized sites of
pseudouridylation [75]. The method, termed Site-specific Cleavage And Radioactivelabeling followed by Ligation-assisted Extraction and Thin-layer chromatography
(SCARLET), has the added benefit of quantitatively detecting the extent to which a
particular Ψ is modified. In addition, mass spectrometry techniques have been developed
to exploit Ψ’s unique physiochemical features independent of CMC conjugation. More
specifically, Ψ’s noncanonical C–C glycosidic bond yields a unique fragmentation
pathway following collision-induced dissociation (CID), the products of which can be
detected by liquid chromatography tandem mass spectrometry (LC-MS/MS) [1].
Site-specific Ψ-mapping for each of the methods summarized above, however,
requires prior knowledge of the Ψ-containing sequence of interest, preventing an
unbiased detection approach. In addition, with the exception of SCARLET, the current
methods have been developed to detect Ψ in relatively abundant RNAs, ruling out
detection of Ψ in more lowly expressed transcripts, such as mRNAs.
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1.6 Statement of the problem
The advent of high-throughput RNA sequencing and the development of increasingly
sophisticated bioinformatic methods to analyze the resulting data have led to the creation
of techniques to specifically map RNA modifications across the transcriptome. For
instance, utilizing an m6A-specific antibody to immunocapture modified transcripts has
allowed for transcriptome-wide localization of m6A, while analyzing specific RT-arrest
and nucleotide misincorporation profiles has led to the global identification of N1methyladenosine (m1A) residues [32,49]. Modification maps have allowed for the
generation of testable hypotheses to continue probing the functional relevance of the
modification in question.
In contrast to the growing body of work pointing to the biological functions of
pseudouridylation, further inquiry was limited by the available methods for site-specific
Ψ detection. For instance, despite pseudouridine’s recoding potential, pseudouridylation
of native mRNA transcripts had never been observed. Elucidating the role of
pseudouridylation in naturally occurring RNAs would therefore require the development
of a high-throughput, unbiased, and sensitive approach to identify Ψs. As a result, I set
out to develop a deep-sequencing approach for Ψ detection, outlined in Chapter 2,
adapting CMC derivatization to a high-throughput format.
During my pilot Ψ-profiling experiments, three CMC-based approaches to
transcriptome-wide detection were published, with a fourth technique released shortly
thereafter. Collectively, these methods — called Pseudo-seq, Ψ-seq, PSI-seq, and CeUseq, in order of publication — catalogued thousands of novel sites of pseudouridylation
across a number of species and in a range of environmental contexts. The availability of
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four independent yet interrelated methods provided a unique opportunity for a critical,
cross-method comparison of their respective results. I therefore undertook such a
comparative analysis, which revealed previously undiscussed shortcomings of each
approach, detailed in Chapter 3. I then applied lessons learned from the caveats I
uncovered to improve the now available Ψ-detection approaches.
The original aim of mapping where Ψ sites are was to understand what Ψ sites do.
In other words, Ψ-detection approaches were developed to better understand the role
pseudouridylation plays in biological systems. As a result, I chose to apply my
improvements to characterize Ψ profiles at two life cycle stages in the digenetic
protozoan parasite Trypanosoma brucei. In so doing, I hoped to begin to unravel the role
differential pseudouridylation might play in cellular differentiation. However, my
preliminary experiments in this system revealed unanticipated concerns surrounding
robust, reproducible high-throughput CMC-based Ψ detection, discussed in Chapter 4.
Beyond pseudouridylation, an underlying theme in this thesis is the importance of
well-documented experimental failure. Therefore, I have attempted to rigorously
investigate and characterize potential sources of my failure to implement high-throughput
Ψ-detection. I hope the work undertaken in this thesis might set an example for how to
transparently and productively discuss caveats and experimental limitations of the
scientific practice more broadly.
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CHAPTER 2. Developing a high-throughput approach for Ψ detection
To gain a better understanding of Ψ and its potential role in modulating cellular function,
we must first know what subset of transcripts are targeted for pseudouridylation and
where in those transcripts Ψ occurs.
Since its introduction in 1993, CMC derivatization and subsequent alkaline
hydrolysis coupled to primer extension has become the primary means of Ψ detection [7].
Despite its popularity, the technique comes with two primary limitations:
1. Primer design requires prior knowledge of the Ψ-containing sequence of interest,
precluding unbiased discovery of pseudouridine residues.
2. CMC-dependent pseudouridine mapping was developed to detect Ψ residues in
relatively abundant RNA species (i.e. rRNAs, tRNAs, snRNAs), where uridine is
highly isomerized to pseudouridine. For instance, the majority of Ψ residues in
Schizosaccharomyces pombe are isomerized from U to Ψ at an efficiency of 85%
or higher [114]. Therefore, low efficiency pseudouridylation events and Ψs in
lowly abundant transcripts, like mRNAs, are unlikely to be detected using the
traditional, low throughput CMC-based approach.
Both limitations can be circumvented with the advent of next-generation sequencing
technologies, which can interrogate the entire transcriptome at high depth for sites of ΨCMC-mediated reverse transcriptional arrest. Coupling CMC conjugation with stranded
RNA sequencing (RNA-seq) therefore allows for mapping of novel Ψ targets, and is the
basis of the high-throughput sequencing approach laid out in this chapter.
2.1 CMC derivatization and alkaline hydrolysis optimization
CMC conjugation is not without its challenges. Specifically:
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1. CMC does not conjugate to all G- and U-like residues with uniform efficiency.
Thus, the presence of underivatized Ψ residues will lead to false negatives [33].
2. Likewise, alkaline cleavage of CMC adducts to non-Ψ residues occurs at
incomplete efficiency, so failure to cleave CMC from G-like and U-like residues
will result in false positives [33].
Conditions for CMC treatment and alkaline hydrolysis vary within the literature,
specifically with respect to three variables: (1) alkaline solution pH, (2) incubation time,
and (3) incubation temperature [7,33]. Before proceeding to a pilot study coupling CMC
derivatization with RNA-seq, it was therefore essential to establish a standardized
derivatization protocol to maximize CMC conjugation efficiency to pseudouridine, while
minimizing RNA degradation resulting from alkaline hydrolysis.
To ensure optimal reaction conditions, a method of monitoring CMC
derivatization and subsequent cleavage from non-Ψ residues was required. As a result, I
collaborated with Dr. Mark Helm’s group at Johannes Gutenberg-Universität Mainz,
where they had synthesized a CMC derivative called N-cyclohexyl-Nʹ-β-(4propargylmorpholinum) ethylcarbodiimide or CMCyne. The compound importantly
contained an alkyne group for Copper(I)-Catalyzed Azide-Alkyne Cycloaddition, the
classic “click” chemistry reaction (Figure 2.1A). To track CMC adducts, I could then take
advantage of a fluorescent azide, atto488, which could be conjugated to CMCyne
following derivatization to its target U- and G-like residues (Figure 2.1B). While atto488
does not provide an absolute measurement of CMCyne conjugation, diminishment of a
fluorescence signal following hydrolysis provided a relative gauge of cleavage efficiency.
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Figure 2.1. Structures of CMCyne derivatives.
(A) Structure of CMCyne with alkyne group in red. (B) Structure of CMCyne conjugated
to pseudouridine (grey) and atto488-azide (yellow) following azide-alkyne cycloaddition.

I first established that CMCyne could conjugate to U- and G-like residues like the
commercially available CMC. In vitro-transcribed tRNA tyrosine (IVT tRNATyr)
containing only unmodified ribonucleotides was therefore derivatized with CMCyne
followed by atto488 conjugation. The product of the reaction was visualized on a 15%
SDS-PAGE gel, which confirmed CMCyne had conjugated to U and G residues in IVT
tRNATyr. Next, I tested a number of conditions for alkaline hydrolysis with 50 mM
(NH4)2CO3 by varying the pH, temperature, and time of the reaction, which are detailed
in Table 2.1.

Table 2.1. Detailed conditions for alkaline hydrolysis optimization.
pH 10.5
Temperature
Time

11.0

11.5

10.5

11.0

11.5

10.5

11.0

11.5

10.5

37˚C

42˚C

2.5 hours

3.0 hours
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11.0

11.5

The schematic for alkaline hydrolysis optimization is detailed in Figure 2.2A.
Following CMCyne conjugation to IVT tRNATyr, samples were subjected to alkaline
hydrolysis under all of the above conditions. Treatment with H2O in place of alkaline
solution was used as a control. Because IVT tRNATyr contains no pseudouridine residues,
all CMCyne should be cleaved from U and G residues under efficient alkaline hydrolysis.
As a result, atto488-azide would have no available substrate for conjugation. I could
therefore monitor CMCyne cleavage efficiency as a loss of fluorescence signal. I also
monitored RNA degradation under alkaline conditions by subjecting my samples to a
GelRed stain following fluorescence imaging on a 15% SDS-PAGE gel (Figure 2.2B).

pH 11.5, 37˚C, 3h

pH 11.5, 37˚C, 2.5h

pH 11.0, 42˚C, 3h

pH 11.0, 42˚C, 2.5h

pH 11.0, 37˚C, 3h

pH 11.0, 37˚C, 2.5h

H2O, 42˚C, 3h

H2O, 37˚C, 3h

H2O, 37˚C, 2.5h

GelRed Stain
pH 11.5, 37˚C, 3h

pH 11.5, 37˚C, 2.5h

pH 11.0, 42˚C, 3h

pH 11.0, 42˚C, 2.5h

pH 11.0, 37˚C, 3h

pH 11.0, 37˚C, 2.5h

H2O, 42˚C, 3h

H2O, 42˚C, 2.5h

treat with CMCyne

H2O, 37˚C, 3h

Fluorescence Scan

H2O, 42˚C, 2.5h

B

IVT tRNATyr
(no Ψ)

H2O, 37˚C, 2.5h

A

CMCyne

alkaline hydrolysis
under different conditions

conjugate atto488-azide
via “click” chemistry
atto488
azide

Figure 2.2. Optimizing conditions for efficient alkaline hydrolysis.
(A) Schematic of perfectly efficient alkaline hydrolysis reaction in which all CMCyne is
cleaved from non-Ψ residues leaving atto488 without a substrate. (B) Following CMCyne
derivatization, samples were subjected to alkaline hydrolysis under a range of conditions.
RNA was visualized on a 15% SDS-PAGE gel, scanned for fluorescence (left), and then
stained with GelRed (right). Samples treated at pH 10.5 are not shown.
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Based on the results detailed in Figure 2.2B, I settled on treatment with 50 mM
(NH4)2CO3 at pH 11.0 at 37˚C for 2.5 hours as sufficiently efficient. Under these
conditions, fluorescence from conjugated atto488 substantially diminished with respect to
the H2O control, while RNA degradation remained minimal.
Finally, I confirmed that under these conditions, I could distinguish a uridine from
a pseudouridine. To do so, I took advantage of two short oligoribonucleotides (~30 nt
long) synthesized by the Helm group; both were identical except one contained a single U
residue, while the other contained a Ψ in its place (Figure 2.3A). Each
oligoribonucleotide was subjected to optimized CMCyne treatment. Following
fluorescent labeling with atto488-azide, the reaction conditions were found to be sufficient
for distinguishing a Ψ from a U within the oligonucleotide (Figure 2.3B).

U

Ψ

+ alkaline hydrolysis

CMCyne derivatization

CMCyne

Ψ
CMCyne

U

oligo-U oligo-Ψ
+ alkaline hydrolysis

B

A

alkaline hydrolysis
atto488-azide cycloaddition

U

Ψ

Ψ

Figure 2.3. Optimized CMCyne-alkali treatment can distinguish Ψ from U.
(A) Schematic of CMCyne-alkali treatment with atto488 conjugation. (B) Derivatization
of the Ψ-containing oligonucleotide results in a fluorescent signal (indicated by arrow),
which is absent in its U-containing counterpart.
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2.2 Pilot high-through Ψ-detection experiment with S. cerevisiae rRNA
Having established an optimized protocol for CMCyne conjugation and subsequent
cleavage, I began a pilot experiment to map sites of pseudouridylation using RNA
sequencing. CMCyne would have been the ideal compound for derivatization because its
alkyne group allowed for conjugation with a biotin-azide, which would in turn allow for
enrichment of Ψ-CMCyne-containing transcripts prior to sequencing. However, the
compound was available only in limited quantity. As a result, I chose to move forward
with commercially available CMC by Sigma for this experiment.
S. cerevisiae (budding yeast) was initially used as a model organism, given the
relative low complexity of the yeast genome, which has the additional benefit of being
very well annotated. I chose to pilot a high-throughput Ψ-detection method on yeast
ribosomal RNAs. In addition to the high abundance of rRNA species (~95% of the
transcriptome), sites of pseudouridylation within yeast rRNAs, as well as snRNAs and
tRNAs, have been well-characterized and corroborated by a number of independent
studies conducted during log phase and stationary phase growth [6,8,103]. Several of
these studies have also attributed specific PUS or H/ACA snoRNA activity to a particular
Ψ [30,41]. A successful high-throughput Ψ-mapping method, which I will call CMC-seq,
would robustly detect these known sites of pseudouridylation with a low false positive
rate, validating the success of my approach.
2.2.1 Library preparation method for pilot CMC-seq experiment
To prepare libraries for CMC-seq, total RNA was extracted from yeast cells grown to log
phase, and treated in duplicate with CMC followed by alkaline hydrolysis; mock-treated
(i.e. without CMC) samples were processed in parallel. Mock-treated libraries ensured
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that premature RT termination sites were due specifically to Ψ-CMC and not, for
instance, natural stops due to RNA secondary structure. Standard library preparation
protocols next call for fragmentation of RNA to a uniform length prior to first strand
synthesis to ensure uniform coverage across the transcriptome (Figure 2.4). However,
because alkaline hydrolysis leads to fragmentation, this step was skipped to avoid
generating sequencing reads that were too small to be reliably mapped back to the
genome. To confirm that hydrolysis resulted in uniform fragment length, I ran samples
before and after treatment on the Agilent 2100 Bioanalyzer system (Figure 2.5).
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Figure 2.4. Schematic of CMC-seq library preparation for total RNA.
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Figure 2.5. Alkaline hydrolysis is sufficient for uniform RNA fragmentation.

Stranded CMC-seq libraries were then prepared by reverse transcription with
random hexameric primers, followed by second strand synthesis to generate doublestranded complementary DNA (dscDNA). Illumina adapters were then ligated onto
dscDNA after end repair and A-tailing, followed by PCR amplification. The resulting
libraries were finally sequenced with the Illumina HiSeq 2000 in 100bp single-end mode.
2.2.2 Initial strategy for data analysis: comparing read coverage in treated
versus mock-treated CMC-seq libraries
The initial strategy for bioinformatic analysis was to first map RNA-seq reads back to a
single rDNA repeat within the rDNA locus of the yeast genome (SacCer3) and calculate
read coverage at each position. Per base coverage was normalized with DESeq to account
for differences in library size [3]. Because Ψ-CMC adducts mediate premature RT arrest,
CMC-treated libraries will exhibit an increase in truncated reads around sites of
pseudouridylation, which translates into valleys in read coverage around the bases
flanking a putative Ψ. By comparison, mock-treated libraries will contain a higher
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number of reads in pseudouridylated regions of transcripts. I therefore calculated what I
called the ‘CMC-stat’ for each position along rRNA (Equation 2.1). I defined CMC-stat
as the log2-transformed ratio of the median number of reads covering a given position in
mock-treated versus treated libraries.

Equation 2.1.

-CMC
CMC-stat = log2 reads at position+CMC
reads at position

The CMC-stat was then plotted for each position along the length of a given
rRNA transcript (Figure 2.6). As predicted, known sites of rRNA pseudouridylation
correspond well with peaks in CMC-stat values for 18S and 25S rRNA as a result of
more reads covering mock-treated transcripts compared to their treated counterparts.
However, peaks were not observed for the shorter 5.8S and 5S rRNAs, which is likely
attributed to a size selection step following dscDNA synthesis that removed fragments of
less than 100 nucleotides in length. In fact, DESeq-normalized read coverage (corrected
for transcript length) of both 5.8S and 5S rRNA is significantly lower than that of 18S
and 25S rRNA (Figure 2.7). Because both transcripts are less than 150 nucleotides long,
reads that spanned the length of the transcripts were enriched following dscDNA cleanup. In other words, short dscDNA fragments resulting from Ψ-CMC-mediated reverse
transcriptional arrest were removed prior to sequencing, particularly given that Ψ is
located roughly in the middle of both 5.8S and 5S rRNA.
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Figure 2.6. CMC-stat plots show broad peaks around clusters of rRNA Ψ sites.
CMC-stat values were plotted for each position along (A) 18S rRNA, (B) 25S rRNA, (C)
5.8S rRNA, and (D) 5S rRNA transcripts. Known Ψs are indicated with red vertical lines.
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While CMC-stat plots were able to qualitatively identify Ψs as peaks in the CMCstat metric, this approach could not computationally pinpoint putative Ψs at single
nucleotide resolution, which is essential to detecting novel targets of pseudouridylation
across the entire transcriptome. If the peaks were of a uniform shape, I could interrogate
the transcriptome for CMC-stat peaks of that same shape to narrow down a set of putative
Ψ sites, which could then be validated using low-throughput methods. However, peak
shape was quite variable, so clear Ψ-calling cutoffs could not be concretely defined, even
based on known sites of pseudouridylation. rRNA represents the best case scenario for Ψ
detection, with its high levels of expression guaranteeing high coverage and its highly
isomerized Ψ residues facilitating a strong Ψ-CMC RT stop signal. Because CMC-stat
analysis was difficult to interpret for rRNA, I concluded that it would be poorly suited for
a transcriptome-wide analysis. As a result, I tested an alternative approach to Ψ mapping,
detailed in the next section.
2.2.3 Alternative data analysis strategy: Analyzing nucleotide misincorporation
during cDNA synthesis to identify Ψs
Post-transcriptionally modified nucleotides have been known to alter reverse
transcriptase processivity [123]. Alterations to the Watson-Crick face of a nucleotide can
impose a roadblock to complementary nucleotide incorporation by the reverse
transcriptional machinery. As a result, the polymerase stalls at the modified site, which in
turn can lead to nucleotide misincorporation. By analyzing RNA-seq data, several groups
have identified characteristic nucleotide misincorporation signatures that distinguish a
particular RNA modification from random sequencing errors [49,50,104].
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Because CMC derivatizes to the Watson-Crick edge of Ψ, and because Ψ-CMC
adducts have been found to cause a “stuttered” stop in RT at the modification site (as
opposed to one base 3ʹ of Ψ), I decided to take a closer look at alternative nucleotide
incorporation frequencies [6]. Given yeast contain over 100 rDNA repeats, intra-genomic
DNA polymorphisms naturally exist among the many gene copies, which must be
distinguished from modification-driven mismatched nucleotide incorporation [58,122]. I
therefore filtered out known polymorphisms from my analysis. In addition, mispriming
events introduced by random hexamers during first strand synthesis and a drop in base
calling quality result in higher sequencing error rates at the ends of reads. As a result, I
trimmed two bases off the ends of each read. Importantly, rRNA positions exhibit
excellent read coverage; however, if this method were applied to the entire transcriptome,
only positions with sufficient coverage should be analyzed to ensure a modificationmediated mismatch can be distinguished from sequencing errors or mis-mapping events.
Following these filtering steps, I calculated the ratio of non-reference nucleotide
incorporation, or the ‘mismatch rate’ (MR), for each position (Figure 2.8A). I then
calculated the log2-transformed ratio of treated versus mock-treated mismatch rates to
compare whether mismatch frequencies at modified nucleobases were indeed higher
(Figure 2.8B). Analysis was next narrowed to a subset of rRNA positions with a median
mismatch rate of greater than 1.5% in treated samples (Figure 2.8A, purple points) and
with over four times the median MR in treated versus mock-treated samples (Figure
2.8B, maroon and green points). The MR cutoff was based on an assumed base-calling
error rate of ~1% using the Illumina sequencing platform [77].

25

A
0.5

Median Mismatch Rate

0.4
Treatment
−CMC

0.3

+CMC
RNA Modification
Ψ

0.2

Um
0.1

0.0
0

500

1000

1500

Position in 18S rRNA

B

log2(MR+CMC/MR-CMC)

4

Pseudouridine?
Yes
2

No
RNA Modification
Ψ
Um

0

−2
0

500

1000

1500

Position in 18S rRNA

Figure 2.8. Non-reference nucleotide incorporation rates for rRNA.
(A) The median mismatch rate was plotted for each position. MRs of greater than 1.5%
are indicated as points. (B) The log2-transformed ratio of treated versus mock-treated
median MRs was plotted for each position. Sites with a greater than four-fold higher
treated mismatch rate of at least 1.5% are indicated as points. Green points indicate a true
Ψ site. Known RNA modification sites are indicated by vertical lines.

With this mismatch analysis, three of 46 total pseudouridines (6.52%) were
successfully detected across all four rRNAs, while an additional 12 called sites were false
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positives. If I included an additional filter to require a ‘U’ as the reference position, the
number of false positives would decrease to three. Clearly, however, employing
mismatch rate as a Ψ-detecting metric is not sufficiently adequate for identifying the bulk
of known Ψ sites. Still, I chose to take a closer look at the alternate nucleotide
incorporation profiles by base of the three true Ψ hits from this mismatch analysis (Figure
2.9, yellow highlight). All three Ψ positions show a clear bias towards sequencing of C
with varying levels of A, which is in line with observations made by other groups, and
with closer inspection of all Ψ residues in my CMC-seq data set [104].
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Figure 2.9. Nonreference nucleotide incorporation profiles at U positions of interest.
Nonreference nucleotide incorporation frequencies for each treated (triangle) and mocktreated (circle) replicate were plotted for true Ψ sites identified during mismatch analysis
(highlighted in yellow). Three additional points of interest were identified and plotted.

In addition, I analyzed the mismatch profiles of three modified sites that had high
mismatch rates in both treated and mock-treated samples: N1-methyl-N3-(3-amino-327

carboxypropyl) pseudouridine (m1acp3Ψ) at position 1191 in 18S rRNA and 2ʹ-Omethyluridines (Um) at positions 2634 and 2843 in 25S rRNA. Interestingly, CMC
cannot derivatize to m1acp3Ψ because both derivatization points on the Ψ base are
otherwise occupied by chemical groups. In fact, this hypermodified nucleotide has been
found to block reverse transcription on its own, likely owing to the acp3 group at the N3
position of Ψ [81]. m1acp3Ψ shows a similar bias towards C(/A) as its non-hypermodified
counterpart. Um, on the other hand, shows a bias towards incorporation of A with
varying levels of G. To date, available methods for Um mapping either take advantage of
2ʹ-O-methylated residues resistance to (1) alkaline hydrolysis, (2) RNase digestion, or (3)
2ʹ-OMe-specific reverse transcriptional stalling under limiting dNTP concentrations
[63,80,129]. Recently, the latter strategy was adapted to a high-throughput format in a
method called 2OMe-seq [55]. However, none of these methods has identified nucleotide
misincorporation at Um as an additional validation strategy for putative Um sites.
Although mismatch analysis is insufficient for robust de novo Ψ identification, I
concluded that adding a filter for a mismatch incorporation profile of C(/A) at a putative
Ψ can serve as an additional bioinformatic layer to increase confidence in that site.
While analysis of my preliminary CMC-seq experiments showed promise for de
novo mapping of Ψ sites, my efforts were interrupted with the concurrent publication of
three similar CMC-based methods for high throughput Ψ-detection. These methods, as
well as a critical analysis of their results, are detailed in the next chapter.
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CHAPTER 3. A comparative analysis of high-throughput Ψ-detection methods2
With interest surrounding pseudouridylation growing — particularly around its potential
role in stabilizing or recoding mRNAs — several groups had independently begun work
developing a high-throughput Ψ-mapping approach similar to CMC-seq. As a result,
within the month of October 2014 alone, three methods were published — called Pseudoseq, Ψ-seq, and PSI-seq, in order of publication — that coupled CMC derivatization with
RNA-seq to map the pseudouridine landscape in yeast and human RNAs [19,76,107].
Shortly thereafter, a fourth group published a similar technique called CeU-seq that
employed a CMC derivative with an azide group for click chemistry, similar to the
principal behind CMCyne [69]. Collectively, these papers revealed hundreds of novel Ψs
that were found throughout the transcriptome. Intriguingly, pseudouridines were found in
mRNA and ncRNA transcripts for the first time. What follows in this section is an outline
of these methods, comparing and contrasting their approaches, and a comparative
analysis of their results, which revealed areas of improvement for high-throughput Ψ
detection.
3.1 Strategies underlying four published high-throughput Ψ-detection methods
Given all four techniques rely on CMC derivatization and subsequent deep sequencing,
little technical difference exists between the library preparation protocols for each (Figure
3.1). All began by treating poly(A)-selected RNA with CMC, followed by alkaline
hydrolysis to selectively label Ψ residues. Following treatment, an adapter was ligated to
the 3ʹ end of RNAs and transcripts were reverse transcribed, with truncated cDNA
2

Portions of this chapter were published in [131].
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products resulting from Ψ-CMC-induced RT arrest. Depending on the method used,
either a 3ʹ adapter was ligated to the resulting cDNAs or RT products were circularized
for subsequent PCR amplification and deep sequencing. As a control, libraries were also
prepared from mock-treated samples processed in parallel.
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Figure 3.1. Four methods of transcriptome-wide identification of Ψ residues are
based on the same CMC-derivatization principles.
Generalized library preparation procedure for Ψ-detection methods. Method-specific
details are highlighted in green boxes.
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While all the aforementioned methods follow the general outline detailed above, a
few notable exceptions exist, particularly in how each method enriches for Ψ-containing
transcripts (Figure 3.1, green boxes). Most notably, CeU-seq chemically enriches for ΨCMC-containing transcripts, as its full name, N3-CMC-enriched pseudouridine
sequencing implies. A CMC-azide derivative was utilized for CMC-treatment, which
allows for biotin conjugation with click chemistry following derivatization and
subsequent hydrolysis. Ψ-CMC-biotin-containing transcripts were then pulled down with
streptavidin beads, increasing the method’s sensitivity with the benefit of approximately
15-20-fold enrichment of pseudouridylated RNAs [69].
The production of truncated reverse transcriptional products due to Ψ-CMC is
central to all four methods and poses unique challenges for bioinformatic detection.
Whereas my initial CMC-seq analyses centered on analysis of read coverage, each of
these methods has developed similarly derived bioinformatic approaches to identify ΨCMC-mediated reverse transcriptional stops to chart the pseudouridine landscape.
Importantly, reverse transcriptional stops correspond to sequencing read starts. Instead
of focusing on overall read coverage for a given RNA position, as I had in my initial data
analysis strategy, each method computationally identified an increase in CMC-treated
reads beginning one position 3ʹ to a putative Ψ with respect to the mock-treated control
(Figure 3.2A). Sites not immediately preceded by a U were removed from analysis.
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Figure 3.2. Ψ-CMC adducts correspond to peaks in read starts.
(A) Sample output of Pseudo-seq, Ψ-seq, and CeU-seq Ψ-detection metrics. (B) Ψ-fc plot
for 18S rRNA generated with data from Schwartz, et al. analyzed using my own custom
scripts. Grey lines indicate known rRNA Ψs. Similarities and differences between Ψs
called by my analysis (MZ) and that of Schwartz et al. (SS) are marked by colored points.

PSI-seq utilized a regression analysis comparing reads initiating at a given
position between treated and mock-treated libraries [76]. Pseudo-seq, Ψ-seq, and CeUseq did not rely on such a statistical approach. Rather, they computationally identified
peaks in the number of reads initiating at a particular U-adjacent site. Ψ-seq and CeU-seq
calculated the ratio of reads (the ‘Ψ-ratio’ and the ‘stop rate,’ respectively) beginning at
each mapped position to the total number of reads covering that position (Equation 3.1)
[69,107]. The treated and mock-treated ratios were then compared to call putative Ψ sites,
requiring the treated ratio, the log2-transformed ratio difference (Ψ-fc), and the number of
reads initiating at that position exceed a particular cutoff. Using RNA-seq data from
Schwartz et al., I replicated their bioinformatic analysis and results in rRNA using
custom scripts (Figure 3.2B). CeU-seq also relied on ‘CMC sensitivity’ — which was
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adapted from related work profiling RNA secondary structure using DMS-mediated RT
stops — as an additional measure of the difference in stop reads at a particular site [31].

Equation 3.1.

Ψ-ratio = stop rate = reads beginning at position
total reads at position

Pseudo-seq utilized a metric similar to the Ψ-ratio/stop rate, calculated with 150nucleotide windows (Equation 3.2, WS) centered on a U site. The number of reads
beginning 1 base 3ʹ of the central U (Equation 3.2, URS) and the total number of reads
initiating at any other position within the window (Equation 3.2, WRS) were determined
for treated and mock-treated libraries to calculate the ‘peak+’ (Equation 3.2) [19]. Peak+
values above a specified cutoff and exceeding a minimal number of supporting reads
were used to call putative Ψs, requiring reproducibility over a given number of replicates.

Equation 3.2.

peak+ = WS ×

URS+CMC – URS-CMC
WRS+CMC – WRS-CMC

With the four published methods now outlined above, two notable differences can
be drawn between their approaches and the one I employed during CMC-seq library
preparation. First, I used random hexamers for priming during first strand synthesis,
which has been found to bias read coverage towards certain 13-mer sequences [48]. In
contrast, the methods outlined in this section prime from 3ʹ ligated adapters for more
uniform coverage of the transcriptome. Second, each method prepared libraries so the 3ʹ
ends of cDNA made during first strand synthesis would correspond to a read start site. Ψ-
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seq did so using paired-end sequencing to sequence both ends of a particular dscDNA.
The remaining three methods employed intramolecular ligation in lieu of 5ʹ adapter
ligation to circularize cDNA following first strand synthesis; the site of RT termination
was thus exactly 3ʹ of the sequencing primer. Because I did not circularize cDNA and
employed 100bp single-end sequencing, I would only sequence the RT stop site if the
dscDNA fragment were less than 100 nucleotides long. Thus, my CMC-seq libraries are
insufficient for detecting an enrichment in read starts at a putative Ψ-CMC site. Indeed, I
attempted a similar approach on my CMC-seq samples — computationally detecting an
enrichment in read stops in place of starts — and could only identify one Ψ in 18S rRNA
(Figure 3.3).
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Figure 3.3. Ψ-seq analysis on CMC-seq libraries detects only one Ψ 18S rRNA.
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3.2 Key results from Pseudo-seq, Ψ-seq, PSI-seq, and CeU-seq
Pseudo-seq, Ψ-seq, PSI-seq, and CeU-seq were all performed on a number of cell types
and growth conditions, revealing a tremendous amount of diversity and complexity in the
pseudouridylation landscape. But before the methods were applied to a transcriptomewide analysis, known sites of rRNA pseudouridylation were first used to calibrate each
method’s respective Ψ-detecting metrics to balance the sensitivity and specificity of each
approach. This analysis also confirmed CMC’s specificity for Ψ derivatization, which
was a concern of mine during CMC treatment optimization. Each method filters for hits
that correspond to a ‘U’ in the transcriptome, which excludes analysis of G residues that
may still be conjugated to CMC due to incomplete hydrolysis. Nevertheless, according
to the Ψ-seq study conducted with log phase yeast, all predicted Ψ sites were either
preceded by a U residue or adjacent to a called Ψ as a result of ‘stuttered’ RT arrest
[6,107]. Additionally, the CeU-seq study demonstrated high specificity of N3-CMC to Ψ,
with no cross-reactivity to U or the G-like inosine [69].
Having established the appropriate computational cutoffs for Ψ-detecting metrics,
Ψ maps were detailed for budding yeast, human cells (HEK293, HEK293T, HeLa, and
fibroblasts), and mouse brain and liver cells. In addition to detecting known sites of
pseudouridylation in tRNAs, snRNAs, and rRNAs, Ψs were found for the first time in a
range of functionally relevant noncoding RNAs and mRNAs [19,69,76,107]. A subset of
these newly identified Ψs were attributed to a specific PUS or Ψ-guiding snoRNA
through a series of systematic knockdown/knockout experiments. Combined, genetic
perturbation experiments and computational analyses linked approximately 20-50% of
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putative Ψs to guide RNA or PUS activity, depending on which Ψ-detection method was
used and which PUSs and snoRNAs were further investigated.
While matching predicted sites of pseudouridylation to PUS or guide RNA
activity indirectly validated a subset of Ψ candidates, Li et al. went one step further,
directly validating four of their hits from CeU-seq. A quantitative, CMC-independent Ψdetection method called SCARLET (detailed in Chapter 1.5) was utilized to verify that
the aforementioned three previously unknown Ψ sites detected in human rRNA were
modified to greater than 90% [69]. Even more intriguingly, SCARLET was applied to
demonstrate U519 in EEF1A1 mRNA was indeed pseudouridylated to approximately
56%, providing the first documented experimental evidence of mRNA pseudouridylation.
Each method also identified a conditionally dependent set of mRNA
pseudouridylation sites. In particular, hundreds of stress-dependent pseudouridylation
events were identified in yeast by Ψ-seq (265 Ψs) and PSI-seq (314 Ψs) analysis of cells
following heat shock [19,107]. 60% of Ψ-seq hits perfectly corresponded to the
conserved Pus7 recognition motif and became undetectable in the pus7 strain, suggesting
Pus7 plays a major role in orchestrating heat-shock-specific pseudouridylation. Notably,
Pus7 had previously been implicated in the inducible modification of U2 snRNA at Ψ56
following heat shock and nutrient deprivation [125]. Stress-induced Ψs were also found
in human cells; CeU-seq profiled sites following heat-shock (464 Ψs) and H2O2 treatment
(477 Ψs), while Pseudo-seq profiled sites in serum-starved versus serum-fed HeLa cells
[19,69]. CeU-seq profiling was additionally performed on mouse cells derived from liver
and brain tissue. 1,741 and 1,543 Ψ sites were identified in brain and liver mRNAs,
respectively; however, only 54 of those sites were shared between the two cell types.
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Remarkably, pseudouridylated transcripts were strongly enriched for tissue-specific
function. For example, Ψ-containing mRNAs from the brain encoded proteins involved in
nervous system development and signal transduction.
3.3 Comparative analyses of approaches reveal opportunities for improvement
The existence of four independent CMC-based deep sequencing approaches for Ψ
detection afforded a unique opportunity for critical comparison of their respective results
to determine the robustness of each approach. Because each was applied to a diverse set
of cell types and growth conditions, I was careful to compare Ψ maps provided only for
transcripts isolated from the same cell line grown under similar conditions. Consequently,
an in-depth analysis was restricted only to yeast cells grown in log phase, though I did
also compare human-derived Ψ maps. The resulting comparative analysis revealed a
subset of high-confidence Ψ sites, independently detected by multiple methods, and
underscored opportunities to improve the available Ψ-detection approaches.
3.3.1 Comparing pseudouridylation candidates in budding yeast
Pseudo-seq, Ψ-seq, and PSI-seq all profiled pseudouridylation events in yeast undergoing
log phase growth (OD600 ≈ 1.0, Pseudo-seq; midlog phase hits were used for Ψ-seq, with
log phase defined as OD600 = 2, though midlog OD600 was undefined; OD600 = 0.6-0.8,
PSI-seq), which became the focus of my comparisons. Analysis was further restricted to
include only Ψ candidates in coding DNA sequences, as UTRs were not analyzed in Ψseq. Because PSI-seq aligned reads to an earlier genome assembly (SacCer2 versus
SacCer3), however, site-specific events could only be compared between Pseudo-seq and
Ψ-seq. Nevertheless, I was able to interrogate the three methods to uncover a subset of
genes with independently called putative Ψs (Figure 3.4, left panel).
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Figure 3.4. Comparative analysis of candidate pseudouridylation targets in S.
cerevisiae during log phase growth.
(A) Putatively pseudouridylated coding DNA regions detected by Pseudo-seq, Ψ-seq, and
two replicates of PSI-seq (left) and site-specific Ψ sites detected by Pseudo-seq and Ψseq (right) were compared to identify overlapping hits. (B) The same analysis was
performed for noncoding transcripts (left) and specific ncRNA-internal Ψ sites (right)
identified by Pseudo-seq and Ψ-seq.

In total, pseudouridylation was detected within the CDSs of 402 unique genes. Of
those genes, however, only RPL11a (a 60S ribosomal subunit protein) was consistently
found to contain a CDS-internal Ψ at position 68. On closer inspection, Ψ239 was
detected in TEF1 (a translation elongation factor) by both Pseudo-seq and PSI-seq, and at
the same position in TEF2 by Pseudo-seq and Ψ-seq. Because TEF1 and TEF2 are
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paralogous genes that resulted from gene duplication, it is likely that one or both
transcripts are pseudouridylated. Importantly, each of these detection techniques is
inherently biased towards detecting sites in more abundant transcripts. Indeed, RPL11a
and TEF1/TEF2 are both within the top 30 most highly expressed genes in the yeast
genome, which may account for their reproducible detection by independent methods
[7,121]. Both Pseudo-seq and PSI-seq cite Pus1 dependency for RPL11a Ψ68, and all
three studies cite Pus4 dependency for TEF1/TEF2. Furthermore, using the lowthroughput CMC-Ψ/RT approach, Lovejoy et al. identified RPL11a Ψ68 in the related
yeast Saccharomyces mikitae and TEF1 Ψ239 in both S. mikitae and S. pombe [76]. The
evident evolutionary conservation of these modifications further points to the potential
biological relevance of these particular pseudouridylation events.
Site-specific pseudouridine candidates identified by Pseudo-seq and Ψ-seq were
next analyzed. Of the 21 overlapping putatively pseudouridylated CDSs, 10 predicted Ψ
positions in 10 genes exactly overlapped (Figure 3.4, right panel, Table 3.1). The mean
distance between the remaining Ψ sites within overlapping CDSs was approximately 740,
ruling out the possibility that non-overlapping sites were the result of stuttered CMC-Ψmediated RT termination. In both studies, five of the ten Ψ sites were also found to be
dependent on activity from the same PUS (either Pus1 or Pus4). While it would be
reasonable to assume that a high Ψ-ratio or peak+ value would increase relative
confidence in a given Ψ site, the Ψs belonging to this overlapping set did not necessarily
have the highest Ψ-detection metrics. In fact, Ψ239 in TEF1/TEF2 just barely passed the
cutoff requirements for Ψ-seq (Table 3.1). Still, given the approximately 2.5 million U
residues in yeast coding sequences, an overlap of 10 independently called pseudouridines
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is highly significant (P = 1.12 × 10-8 by the hypergeometric test), increasing confidence
that this set contains true targets of pseudouridylation. It is worth noting, however, that
while all Ψ members of this set were also detected by Pseudo-seq under post-diauxic cell
growth, only one (Ψ1916 in KAR2) was detected by Ψ-seq following heat shock.

Table 3.1. CDS-internal Ψ candidates detected by Pseudo-seq and Ψ-seq.
Ψ-seq metrics
Coordinate
Gene
Position in Gene
Ψ-ratio
Ψ-fc
chr10:383242
KAR2
1916
not available not available
chr16:126070 YPL225W
65
not available not available
chr4:331025
BDF2
2
0.66
4.25
chr3:51028
GLK1
191
0.29
4.31
chr10:314164
MPM1
709
0.24
4.66
chr2:477909 TEF2 (TEF1)
239
0.11
3.17
chr1:32596
GDH3
1030
0.23
5.41
chr16:731681
RPL11A
68
0.23
3.5
chr8:499441
RPN10
383
0.17
3.74
chr7:623051
YGR067C
1736
0.14
3.78

Pseudo-seq
metrics
+
peak
2.82
1.15
13.90
7.03
2.02
6.25
3.52
11.97
5.96
2.68

The minuscule percentage of overlapping pseudouridylated CDSs (~0.5%) and
specific Ψ positions (~3.2%) does nevertheless highlight the limitations of the highthroughput detection of pseudouridylation events. Specifically, because high coverage at
each surveyed position is essential to robust Ψ detection, the output of each method is
highly dependent on sequencing depth, which likely varied between each group. All the
methods outlined above also favor specificity over sensitivity, which necessitates rather
conservative cutoffs for Ψ detection. As a result, the reported Ψs are likely a small
sampling of several true pseudouridylation events missed by each method. Additionally,
the efficiency of native mRNA pseudouridylation has not been concretely established and
may be highly variable [61]. Karijolich et al. noted low isomerization efficiency (~7-
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10%) when artificially targeting mRNA pseudouridylation, while the one experimentally
verified native Ψ target identified by CeU-seq was pseudouridylated to a much higher
extent (~56%) [61,69]. High variance in the efficiency of naturally occurring
pseudouridylation events coupled with stringent Ψ-detection cutoffs therefore introduces
yet another challenge to reproducible Ψ mapping.
A core finding of all four Ψ-detection methods was the conditional inducibility of
pseudouridylation, which further complicates Ψ profiling. Changes in the Ψ landscape in
response to large environmental perturbations were investigated; however, the robustness
of particular pseudouridylation events to smaller environmental fluctuations was not
examined. For instance, small differences in CO2 levels in the incubators of different
laboratory spaces may produce different Ψ landscapes. The difference in Ψs identified by
these different methods may then be a reflection of biological fluctuations in
pseudouridylation in even slightly different environmental contexts. Furthermore, all of
the above methods query pseudouridylation events in populations of cells, aggregating
cells that likely differ, for instance, in cell cycle stage or microenvironment. These
distinct subpopulations may likewise differ with respect to pseudouridylation substrates.
Population averaging effects may thus be an additional contributor to variance. We may
speculate, then, that the Ψs identified by multiple methods are more frequently
pseudouridylated under a broader spectrum of environments, suggesting they play some
core role in mRNA structure or function, at least under logarithmic cell growth.
With the above challenges in mind, I turned my attention to analyzing the set of
pseudouridines detected in noncoding transcripts in log-phase yeast, excluding rRNAs.
Because PSI-seq did not detail Ψs in this subset of transcripts, I compared only the
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outputs from Pseudo-seq and Ψ-seq. Here, the percentage of pseudouridylated transcripts
(~30%) and specific Ψ sites (~20%) independently detected by each method was
markedly greater and highly statistically significant (P = 6.25 × 10-9 by the
hypergeometric test) (Figure 3.4B). This overlap is well in line with the generally higher
expression of ncRNA species with respect to their protein-coding counterparts. Important
to note as well, these ncRNA transcripts include snRNAs and tRNAs — long established
targets of site-specific pseudouridylation. Moreover, Ψ is known to be essential for
proper structure and function of these classes of RNAs, necessitating constitutive
modification of specific uridine residues. Combined, higher expression and functional
importance thus facilitate reproducible Ψ detection by multiple methods.
3.3.2 Comparing pseudouridylation candidates in human cells
Pseudo-seq detailed the Ψ landscape for epithelia-derived HeLa cells, Ψ-seq for a
combination of embryonic kidney-derived HEK293 cells and fibroblasts, and CeU-seq
for HEK293T cells. While the comparative analysis undertaken above would suggest that
these three methods are not directly comparable, I still wondered if I might determine to
what extent pseudouridylation was conserved across all transcripts in these different
human cell types. Importantly, CeU-seq pre-enriches for Ψ-CMC-containing transcripts
by up to 20-fold to increase the method’s sensitivity to low-abundance transcripts, which
accounts for the large difference in the reported number of hits with respect to Pseudoseq and Ψ-seq. Pseudo-seq-analyzed HeLa cells shared no putative Ψs with HEK293T
cells or the combination of HEK293 cells and fibroblasts, aside from the previously
mentioned Ψ5160 and Ψ5590 in the lncRNA MALAT1. The lack of commonly predicted
Ψs between these cell lines derived from different tissues is in line with the low overlap
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in Ψ sites detected by CeU-seq in mouse brain and liver cells [69]. On the other hand,
HEK293/fibroblast cells and HEK293T cells shared 47 putative Ψs out of the 396 and
2,084 called sites in Ψ-seq and CeU-seq, respectively. Rather interestingly, nearly 90% of
those overlapping positions were detected in mRNAs, distributed primarily in the 3ʹ UTR
and CDS regions. Once again, the magnitude of each method’s respective Ψ-detecting
metrics (Ψ-ratio, Ψ-fc, and stop rate difference) does not necessarily correlate with their
inclusion in this overlapping set.
3.3.3 Conclusions from comparative analysis of cross-method putative Ψ sites
Of the many pseudouridylation events that have been collectively identified by the
available Ψ-detection methods, a small subset has been identified by more than one
study, further increasing confidence in the Ψ-detecting power of these techniques with
the necessary caveats detailed above. Nevertheless, the motivation behind developing
such Ψ-detection methods is to elucidate the functional role of this modification. Having
further established Ψ’s ubiquity by cataloguing a remarkable number of putatively
modified sites, it is imperative to next narrow down the list to a set of promising, robustly
modified and detectable candidates to interrogate experimentally through, for instance,
site-specific Ψ knockout experiments. While comparing the outputs of each respective
method has filtered the set of putative Ψs for yeast grown to log phase (and to a lesser
extent for HEK293/HEK293T/fibroblast cells), to perform all four methods for every cell
type and growth environment of interest is impractical. Consequently, each method could
benefit from additional parameters that measure the extent to which a given uridine is
isomerized, particularly because a high Ψ-detection metric from any one method does not
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guarantee detection by an independent technique. I propose one such parameter in the
following section.
3.4 Towards quantitative Ψ profiling: a case for molecular barcoding
Of the four methods for high-throughput Ψ detection, Ψ-seq was the only to demonstrate
its ability to quantitatively capture the relative level of pseudouridylation by comparing
the Ψ-ratios at a particular position across two or more samples. This quantitative power
was demonstrated in a synthetic spike-in experiment that mixed different ratios of
oligoribonucleotides that either contained a Ψ at a specific site or not [107]. Importantly,
however, Ψ-seq was unable to measure absolute levels of pseudouridylation within a
given sample, perhaps reflecting incomplete CMC derivatization to Ψ residues or ΨCMC readthrough events. For instance, ribosomal pseudouridines are considered to be
constitutively modified at near 100% efficiency. Recent work in S. pombe has
experimentally demonstrated that the majority of pseudouridylated residues in rRNA are
indeed highly modified (>85% isomerization) [114]. I was therefore curious to examine
the variation in Ψ-ratios across ribosomal pseudouridines identified by Ψ-seq, given this
method’s special focus on quantitative measurement (Figure 3.5A).
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Figure 3.5. Ψ-detecting metrics are unable to provide absolute quantitation of
pseudouridlyation levels.
(A) Ψ-ratios of known sites of pseudouridylation in 18S and 25S rRNAs detected by Ψseq were plotted to assess the variance at each position and across all positions. (B) The
same analysis was applied to the peak+ Ψ-detection metric used in Pseudo-seq.

Ψ-ratios are remarkably reproducible among replicates at a given position, which
well supports Ψ-seq’s ability to quantitatively compare Ψ levels between samples.
However, the relatively uniform level of rRNA pseudouridylation is not reflected in the
variable distribution of Ψ-ratios across all rRNA positions. A similar trend can be seen in
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the peak+ Ψ-detection metric utilized by Pseudo-seq, though peak+ values exhibit a higher
degree of variability at each position (Figure 3.5B). Variation at a given Ψ residue
reflects the variability intrinsic to RNA-seq library preparations using the CMC/RT
approach, which requires multiple steps that likewise introduce multiple opportunities for
inconsistency in the hands of different operators. Variation across all known rRNA Ψ
residues, however, may be the result of chemical limitations inherent in CMC’s ability to
uniformly derivatize to pseudouridine, which may be due, for instance, to restrictions
imposed by RNA secondary structure or interference from surrounding RNA
modifications. While studies have been undertaken to optimize CMC derivatization
efficiency, substrate preferences for CMC derivatization, if any, have not been
characterized and published [33].
An alternative explanation to intrasample variability in Ψ-detection metrics lies in
the high sequencing depth required for each method outlined in this chapter. Increasing
sequencing coverage captures more rare cDNA fragments resulting from lowly expressed
transcripts; however, increased depth also results in sequencing redundant PCR
amplification products more frequently. This trade-off is particularly important given that
each of the Ψ-detection techniques identify putative Ψs by an enrichment in identical
reads initiating at the same position. Importantly, single-end sequencing produces ΨCMC-derived reads that are indistinguishable from PCR duplicates (assuming no
mismatches). Discarding duplicates therefore interferes with Ψ-detecting power, as
multiple Ψ-CMC-initiating reads are collapsed into one (Figure 3.6). Requiring several
replicates for confident Ψ detection does mitigate the possibility of false positive Ψ calls
due to PCR duplicates. Still, it is difficult to determine the true proportion of reads
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initiating at a position due to Ψ-CMC, which could more accurately reflect the level of
pseudouridylation at that position. Notably, Ψ-seq performed paired-end sequencing,
which improves read mapping resolution by sequencing both the 5ʹ and 3ʹ ends, to the
extent that cDNA fragment length is sufficiently diverse. Redundant reads can therefore
be collapsed with reduced loss of sequencing information (Figure 3.6).
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Figure 3.6. Molecular barcoding improves quantitation of unique reads initiating
from Ψ-CMC adducts.
Schematics of PCR duplicate removal of Ψ-CMC-derived reads using single-end RNAseq (purple box), paired-end RNA-seq (purple and green boxes), and paired end RNA-seq
coupled with molecular barcoding (purple, green, and multi-colored boxes) are depicted.
Depending on the sequencing mode used, more reads may be retained.

The requisite sequencing depth may still be ensured while conserving reads
resulting from identical Ψ-CMC-derived cDNA fragments (as opposed to identical PCR
duplicates). Coupling molecular barcoding with RNA-seq has been shown to more
accurately and reproducibly quantify the absolute number of cDNA fragments in a given

47

sample [40,109]. I therefore proposed similarly incorporating short randomized DNA
sequences, through end ligation or reverse transcription, prior to PCR amplification to
uniquely identify cDNA fragments. The specific length of the barcodes is dictated by the
size and complexity of the transcriptome under investigation [20,39]. Replicate clones
due to PCR amplification are identified as reads with matching barcodes and sequences
that map to the same location. These reads are then collapsed into one, allowing for
single-copy resolution. Most importantly, identical reads initiating from the same position
due to Ψ-CMC may be distinguished by their unique barcodes, providing absolute
quantitation of the number of reads initiating at and covering a given position (Figure
3.6). In other words, the number of unique barcodes, rather than the number of reads,
would be used to count and calculate the relevant Ψ-detection metrics. While molecular
barcodes cannot completely overcome limitations due to inefficient CMC conjugation,
barcoding provides a more quantitative approach that could facilitate a more direct
comparison of pseudouridylation levels across putative Ψ sites by comparing absolute
proportions of reads. Furthermore, the extent to which given positions are
pseudouridylated provides additional information to discern which particular Ψ residues
are most promising for further functional investigation.
In the next chapter, I employed an approach coupling Ψ-seq with molecular
barcoding to attempt to identify novel sites of pseudouridylation using the African
trypanosome, Trypanosoma brucei, as a model organism. I also examined the feasibility
of incorporating nonreference nucleotide incorporation patterns as an additional point of
validation for putative Ψ sites.
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CHAPTER 4. Improving high-throughput Ψ detection in Trypanosoma brucei
The purpose of developing an unbiased, high-throughput approach for Ψ detection was
ultimately to expand our understanding of the biological role of pseudouridylation
beyond a relatively small subset of cellular RNAs. Each of the published methods
catalogued hundreds to thousands of novel pseudouridylation sites, a very small subset of
which have been identified by more than one study. However, beyond a GO term analysis
of putative Ψ-containing transcripts, these studies did little to experimentally ascertain a
physiological role for pseudouridylation to a given transcript. For instance, does Ψ alter
the half-life of a particular transcript in response to stress that is necessary to facilitate a
biological stress response?
My comparative analysis of the currently available Ψ-detection approaches
detailed in the previous chapter shed insights into opportunities for improvement that I
sought to apply while simultaneously probing the physiological function of this
ubiquitous modification. In this chapter I discuss my work coupling a molecular
barcoding scheme with the Ψ-seq method laid out by Schwartz et al. in order to detail the
pseudouridylation profiles of Trypanosoma brucei at two distinct points of the parasite’s
life cycle.
4.1 Utilizing the T. brucei life cycle as a model system to investigate the functional
consequences of differential pseudouridylation
The conditional inducibility of pseudouridylation has been demonstrated under a number
of different conditions of environmental stress and nutrient deprivation by both lowthroughput and high-throughput means of Ψ detection [19,69,76,88,107,124,125]. In
addition, pseudouridine has been implicated in initiating a cellular differentiation
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program in yeast, and distinct tissue-specific Ψ profiles have been detailed in mice
[11,69]. The growing catalog of inducible Ψ sites has thus strengthened the hypothesis
that pseudouridylation fine-tunes gene expression in response to changing environmental
conditions, adding a post-transcriptional layer to gene regulation by, for instance, altering
pre-mRNA splicing or recoding specific mRNA codons. In fact, Schwartz et al. more
closely examined the possibility that Ψ may contribute to enhanced transcript stability by
examining the abundance of mRNAs containing heat-shock-induced Ψs [107]. A large
subset of these induced Ψs were attributed to Pus7 activity; so mRNA expression levels
were compared in wild-type versus Δpus7 strains under normal and heat-stressed
conditions. While Ψ-containing transcripts were expressed at comparable levels between
wild-type and Pus7-deficient cells under normal growth conditions, these transcripts were
expressed at ~25% higher levels following heat shock in wild-type cells [107].
As a result, I chose to investigate the biological implications of pseudouridylation
at two points during the T. brucei life cycle, which is an ideal model system for reasons
detailed in this section.
4.1.1 T. brucei differentiation requires adaptation to different host environments
African trypanosomes are unicellular protozoan parasites that are the causative agents of
African trypanosomiasis — African sleeping sickness in humans and nagana in their
vertebrate zoonotic counterparts — affecting sub-Saharan Africa. Within the lab, the
most commonly studied and well-characterized species of trypanosome is T. brucei
brucei, which is the focus of the experiments detailed in this chapter.
T. brucei is transmitted between its mammalian hosts through the tsetse vector
(Glossina sp.). Because the parasite lives extracellularly throughout the entirety of its life
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cycle, it must adapt to a variety of host-specific environmental conditions differing in pH,
nutrient availability, and temperature that cue a particular set of diverse biological
changes (Figure 4.1). Following a bloodmeal, the parasite establishes in the tsetse midgut
— a relatively cool environment (27˚C) with low pH and a variety of harsh proteases —
and differentiates into its proliferative, asexual procyclic form (PF) [43,83]. From there,
procyclic forms migrate to the fly’s salivary glands where they attach and differentiate
into the epimastigote form, which is capable of undergoing meiosis allowing for
diversification through genetic recombination [44]. Eventually, epimastigotes develop
into non-proliferative metacyclic form parasites capable of infecting a mammalian host
through the fly’s next bloodmeal [83]. On bite, metacyclic trypanosomes migrate from
the skin into the glucose-rich bloodstream, where they differentiate to the aptly named
bloodstream form (BSF). Early during infection, BSF parasites adopt the long ‘slender
form,’ dividing rapidly both in the bloodstream and within the extravascular space (with
its own distinct metabolic requirements) until they reach high density and develop into
the non-dividing ‘stumpy form’ [100,116]. Interestingly, stumpy BSF parasites are
primed for transfer into the tsetse midgut, as they exhibit increased resistance to acidic
and proteolytic stress [60,93].
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Figure 4.1. The life cycle of T. brucei.

The biological feat required to rapidly adapt to and differentiate in diverse host
environments is well-reflected in this particular passage from Gibson et al.:
“The trypanosomes migrate anteriorly from this
stronghold [in the midgut] on a tortuous journey to the
paired salivary glands [43].”
The life cycle of T. brucei therefore provides an excellent biological context for hostdependent inducible pseudouridylation to further probe the role of Ψ in adaptation and
differentiation.
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4.1.2 Gene expression in T. brucei remains mysterious and occurs largely at the
post-transcriptional level
Highly programmed differentiation is made all the more impressive considering the
organization — or lack thereof — of the T. brucei genome. Specifically, protein-coding
genes are arranged in polycistronic transcription units (PTUs) encoding ten to hundreds
of mRNAs (Figure 4.2). Genes oriented in the same direction are co-transcribed and
rapidly processed through coordinated trans-splicing, endonucleolytic cleavage, and
polyadenylation at a fixed distance from the splice signal, resulting in mature mRNA
transcripts [84,117]. Notably, trans-splicing requires joining of a small, capped spliced
leader (SL) RNA to the 5ʹ end of a pre-mRNA [72]. The SL notably contains Ψ at
position –12 with respect to the splice acceptor site. Pseudouridylation at this residue is
catalyzed by the RNA-dependent Ψ synthase Cbf5 guided by the spliced leaderassociated (SLA1) RNA, an H/ACA snoRNA [72]. In contrast to yeast and mammalian
mRNAs surveyed for pseudouridylation, all mature mRNAs contain at least a single Ψ.

Polycistronic Transcription Unit
(PTU)

transcription

mRNA processing

SL

AAAAAA

SL

AAAAAAAAAAAAAA

AAAAAAAAAAAAAA
AAAAAA

SL

SL

SL

AAAAAAAA

SL

AAAAAAAA

Figure 4.2. Schematic of T. brucei and mRNA post-transcriptional processing.

Though PTUs resemble bacterial operons, genes within a given polycistron
appear to lack functional clustering, with the exception of the alternating α/β-tubulin gene
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array [18]. In addition, while pol I promoters (responsible for rRNA and life cyclespecific surface protein transcription) and pol III promoters (responsible for tRNA and
small nuclear U RNA transcription) have been identified, pol II promoters responsible for
the bulk of mRNA transcription remain elusive. In fact, only one gene-specific pol II
promoter has been identified for transcription of the small spliced-leader RNA [27,46]. A
growing body of work has pointed to histone marks to delineate the boundaries of
transcription, and has suggested that histone modifications may regulate polycistronic
transcription [101,106,111]. For instance, while pursuing the Ψ-profiling efforts detailed
in this thesis, I, in collaboration with Danae Schulz and Hee-sook Kim, found that the
histone variant H3 (H3.V) and a kinetoplastid-specific DNA base modification known as
base J (ß-D-glucosyl-hydroxymethyluracil), together regulate transcription termination
[106]. In the kinetoplastid Leishmania major, depletion of base J alone has been shown to
be sufficient to result in transcriptional readthrough at sites of transcription termination
[101,118]. Still, transcriptional control at the individual mRNA level appears impossible
given the lack of promoters or other cis-regulatory elements specific to a single PTUinternal gene [25]. Control of mRNA levels therefore occurs primarily at the posttranscriptional level.
Individual gene regulation is achieved by modulating mRNA stability, translation
efficiency, and protein stability. Interestingly, a transcriptome-wide study analyzing the
kinetics of trypanosome mRNA decay reported regulated decay of developmentally
regulated mRNAs, switching their decay patterns during differentiation [35]. The specific
mechanism of this life-cycle dependent “switch” is largely unknown, though the T. brucei
genome encodes a wealth of RNA-binding proteins (RBPs) with unknown RNA targets
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[18]. Several groups have therefore undertaken the task of identifying conserved motifs
that regulate developmental gene expression. For instance, a specific 3ʹ UTR sequence
motif (UAUUUUUU) has been found to be highly conserved in procyclic-enriched
transcripts, and makes up the core of a 26mer element negatively regulating expression in
the bloodstream form [85]. However, developmentally regulated expression of these
motif-containing genes was unaffected by the RNA silencing machinery, leaving open
the question of how exactly these transcripts are stage-specifically stabilized or
destabilized. This is in line with the finding that differentiation progresses normally in
Argonaute1-deficient cells [59].
Gene regulation has also been observed through alternative trans-splicing of the
spliced leader RNA, which can affect gene regulation by altering the open reading frame.
Because polyadenylation occurs at a fixed distance from the splice acceptor site,
alternative splicing can also affect polyadenylation site choice, which can impact RNA
half-life by changing the 3ʹ UTR [84,120]. Spliced leader trapping experiments
illuminated over 2,500 alternative splicing events, several of which appeared to be
developmentally regulated [92].
The examples of gene regulation summarized above are by no means
comprehensive. Rather, they serve to illustrate the gaps in our understanding of gene
regulation at the post-transcriptional level, and areas in which investigation into the
developmental Ψ landscape may bridge some of those gaps.
4.1.3 Pseudouridylation has been documented and studied in T. brucei
Having laid out some of the intriguing quirks surrounding trypanosome biology and
differentiation, it merits mentioning that Ψ has been relatively well studied in T. brucei,
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which is helpful for studying functional consequences of pseudouridylation in this model
organism. As in other eukaryotic cells, pseudouridine formation is catalyzed by a guide
RNA-dependent mechanism through the activity of Cbf5 guided by H/ACA snoRNAs,
and likely through the activity of a number of putative Ψ synthases that bear homology to
known stand-alone PUSs [10]. T. brucei H/ACA snoRNAs notably differ from those of
other eukaryotic cells in that they are composed of only a single hairpin, in contrast to the
more common double hairpin structure [73]. Recent small RNA-seq experiments have
identified 83 H/ACA snoRNAs capable of guiding pseudouridylation and 79 C/D
snoRNAs, which guide 2ʹ-O-methylation [24,89].
Sites of pseudouridylation have also been documented within the T. brucei
genome. Aside from the aforementioned Ψ-containing SL transcript, Ψs have been
mapped within ribosomal RNAs using the traditional low-throughput CMC/RT approach
[71]. In addition, a recent study published by Chikne et al. during the writing of this
thesis catalogued additional sites of ribosomal pseudouridylation in BSF and PF
trypanosomes [24]. In total, 68 of 75 known Ψs were identified across the two life cycle
stages, with 62 of those sites mapping to a specific H/ACA snoRNA guide. Despite
having a similar genome size as budding yeast, trypanosomes have over 20 more
ribosomal pseudouridylation events. A possible explanation for higher Ψ content with
respect to yeast ribosomes is that more ribosomal Ψs may allow the trypanosome to
rapidly adapt to fluctuating temperatures as it cycles between hosts while preserving the
structural integrity of the ribosome, or possibly modulating ribosomal function [10].
Notably, Chikne et al. reported that the level of isomerization from U in 21 Ψs was
increased 1.3- to 2.7-fold in BSF ribosomes by comparing Ψ-fc values at a given position
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between BSF and PF parasites. A corresponding upregulation of 43 H/ACA snoRNAs
was also observed in the bloodstream form, though they did not guide pseudouridylation
to the “hyper” modified BSF Ψ sites.
Life cycle-specific differential levels of pseudouridylation in the trypanosome
ribosome requires closer investigation than what was conducted by Chikne et al.
Comparison of Ψ-fc values to ascertain relative Ψ stoichiometries between any two
samples depends on a qualitatively “high” sequencing depth; the exact depth, however,
has not been experimentally confirmed in biological samples using low-throughput
quantitative assays like SCARLET [75,107]. Modest differences in Ψ-fc values between
BSF and PF Ψ sites therefore warrant closer investigation, particularly as the source of
their “hyper” modification remains unknown. Furthermore, differential levels of
pseudouridylation in the ribosomes of BSF compared to PF trypanosomes implies that at
least some ribosomal Ψ residues are modified at low efficiency. For instance, if a Ψ
residue is modified at a level 2.7-fold greater in BSF versus PF trypanosomes, it cannot
be isomerized at a level greater than 37% in the procyclic form. This implication runs
counter to the prevailing observation that ribosomal pseudouridylation occurs at a nearuniform high efficiency of >85% in yeast and human ribosomes [69,114]. The finding
thus warrants absolute quantification of uridine isomerization at differentially modified Ψ
sites using SCARLET or mass spectrometry, which was notably not performed by
Chikne et al. Still, eight of the 21 differentially pseudouridylated sites were predicted to
impact rRNA structure, which may contribute to fine-tuning ribosome function in a given
host environment. Perturbation of these sites in order to determine whether changing Ψ
levels is necessary for transitioning through the life cycle remains an open question.
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4.1.4 Statement of the problem
Taken together, the adaptation required to differentiate in a new host environment and the
lack of gene-specific transcriptional regulation make T. brucei an ideal model system for
probing the functional relevance of Ψ. Certainly, developmentally regulated
pseudouridylation events are an intriguing possibility for modulating RNA function. I
therefore selected bloodstream form and procyclic form trypanosomes for Ψ profiling due
to the ease with which they are cultured in the laboratory. I could then ask whether
pseudouridylation events were developmentally regulated based on differential Ψ
profiles. If BSF- and PF-specific Ψ profiles did indeed differ, I could ask how
developmentally regulated Ψs contribute to differentiation. There are, of course many
possibilities, which include, but are by no means limited to:
1. Ψ-containing transcripts may exhibit increased stability, which could
contribute to their upregulation in one life cycle stage compared to the other.
2. Ψ-containing transcripts may affect translational efficiency. Specifically,
pseudouridylation to mRNA codons, tRNA anticodons, or rRNA may mediate
amino acid recoding resulting in altered protein products, or may enhance or
impede translational efficiency.
3. Differential pseudouridylation of spliceosomal U RNAs may alter pre-mRNA
splicing, which could, for instance, alter RNA half-life by changing the site of
polyadenylation, changing the open reading frame, or decreasing the
efficiency of mature RNA processing.
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4.2 Experimental design with molecular barcodes
The additional quantitation afforded by coupling molecular barcoding to Ψ-seq could
serve to more robustly differentiate levels of pseudouridylation between bloodstream
form and procyclic form trypanosomes beyond comparison of Ψ-fc values. Before
proceeding, I had to develop and test a molecular barcoding strategy experimentally
suited for Ψ-seq library preparation with trypanosome RNA, and develop a bioinformatic
pipeline for subsequent deduplication and analysis. The results of my pilot experiments
and deduplication analysis are detailed in this section.
4.2.1 Molecular barcode design
Library preparation proceeded exactly as detailed by Ψ-seq (Figure 3.1), except the 3ʹ
adapters ligated onto RNA fragments were specially designed to contain a molecular
barcode (Figure 4.3A). Given T. brucei’s relatively small genome size (26 Mb), a
randomized 6mer would be sufficient to serve as a barcode sequence to distinguish up to
4,096 (46) unique reads initiating from a given position. Regardless of the barcode
sequence, every adapter contained a common 5ʹ 4mer ligation linker and a 3ʹ 20mer
sequence selected from the Cyprinus carpio (carp) genome not found in T. brucei for
priming during first strand synthesis (FSS). As an additional consideration, nucleotide
diversity is essential during initial rounds of sequencing for accurate cluster coordinate
identification by the Illumina HiSeq 2000/2500 [65]. Under paired-end sequencing,
though, the common 20mer priming sequence will act as the start of the ‘left-hand’ read,
so the initial 20 cycles of sequencing will be identical, impeding effective cluster calling
(schematic of paired end reads depicted in Figure 4.3C). To increase sequence diversity, I
therefore designed FSS primers complementary to the common priming sequence that

59

either contained two, one, or no randomized nucleotides at to the 5ʹ end (Figure 4.3B).
The three classes of primers were mixed in equal proportions during first strand synthesis
to phase the common priming sequence during sequencing. To further increase diversity,
I had also initially designed three adapters (A, B, and C), which differed only in the
common priming sequence selected from carp DNA, to generate libraries for different
replicates, which were then pooled and run on a single lane.

ligation
linker

A
5′

common priming
sequence (carp DNA)

3′

B
5′

Ψ

3′

CMC

C

FSS primer

5′

FSS primer

–N

FSS primer

–NN

‘right-hand’ read

5′

3′
‘left-hand’ read

Figure 4.3. 3ʹ adapter design with molecular barcodes.
(A) Schematic of 3ʹ adapters with randomized 6N molecular barcode. (B) First strand
synthesis with priming by one of three possible 0N/1N/2N FSS primers ensures phasing
of the common priming sequence. (C) The resulting cDNA will have the adapter at its 5ʹ
end, read as the ‘left-hand’ read, and the Ψ-CMC-mediated RT arrest site at its 3ʹ end,
read as the ‘right-hand’ read start.
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4.2.2 Pilot experiment reveals barcode diversity is essential for deduplication
In a pilot experiment to test the feasibility of my barcoding scheme, I isolated poly(A)enriched RNA from BSF and PF trypanosomes, and prepared barcoded Ψ-seq libraries
for CMC-treated and mock-treated (input) samples in duplicate. Following 50bp pairedend sequencing, I designed a custom tool to computationally subset ‘left-hand’ reads that
contained the common priming sequence, along with the partnered ‘right-hand’ reads,
and extracted the downstream barcode sequence (Figure 4.3C). Because adapter
trimming from left-hand reads resulted in reads too short to be mapped, only right-hand
reads were used for alignment, first to the rDNA locus using bowtie2. Reads unmapped
to rDNA were then mapped to the whole genome. The results for BSF samples from this
initial experiment are summarized in Table 4.1.

Table 4.1. Summary of results for BSF samples prepared using Ψ-seq with
molecular barcoding scheme.
Sample

Adapter

Reads with
Barcode

Barcode
Reads of
High Quality

Mapped to
rDNA

Mapped to
Genome

input-BSF-1

C

79.89%

99.56%

6.98%

59.04%

input-BSF-2

A

65.86%

99.08%

3.94%

29.24%

treated-BSF-1

A

73.45%

99.48%

4.38%

57.51%

treated-BSF-2

B

13.31%

99.37%

4.75%

52.81%

On average, about 60% of sequenced reads contained barcoded adapter sequence,
and of those, over 99% were determined to be of high quality by trim_galore (Babraham
Bioinformatics). Libraries prepared with adapter B, however, contained substantially
fewer barcoded reads, perhaps due to inefficient ligation compared to adapters A and C.
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Nevertheless, reads resulting from libraries prepared with all three adapters mapped to
the genome, so I next confirmed that a 6N barcode was sufficient for deduplicating
genomic reads. To do so, I calculated the number of reads initiating at a given position in
the genome (Figure 4.4). Indeed, all but six positions were covered by less than 4,096
reads initiating at a particular position, indicating that the barcode length was sufficient,
assuming that each unique read was in turn marked by a unique barcode sequence.

log10(Reads Initiating at Position)

log10(4096)

3

2

1

input-BSF-1

input-BSF-2

treated-BSF-1

treated-BSF-2

Figure 4.4. Barcode length is sufficient for deduplication of reads mapping to the T.
brucei genome.
log10-transformed reads mapping to every position within the T. brucei genome were
plotted for each BSF Ψ-seq library. log10(4,096) is indicated by the red horizontal line.

Having established that 4,096 unique barcodes is sufficient for deduplication, I
next proceeded to remove reads that appeared to result from PCR duplicates. To do so, I
computationally eliminated reads that initiated at the same position and contained the
same barcode sequence (Figure 4.5). Depending on the adapter used, between 18-95% of
reads were eliminated following deduplication. I was concerned by the range in the
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proportion of discarded reads because it implied that library complexity varied widely
across samples. However, because the variability in reads discarded following
deduplication was largely due to the 3ʹ adapter used during library preparation, I chose to
investigate the diversity of specific 6mer barcode sequences (Figure 4.6). To do so, I
plotted the number of reads with a given barcode against all 4,096 barcodes. While all
possible barcodes were represented within the total population of reads, adapters A and B
contained a marked overrepresentation of a specific 6mer sequence. Adapter C also
contained bias towards certain 6mers, but to a far less pronounced degree, which
accounts for the higher proportion of reads retained following deduplication.

(Relative to Reads Before Deduplication)

Fold Change in Initiating Reads at a Given Position

1.00

0.75

Before Deduplication

0.50

After Deduplication

0.25

0.00
input-BSF-1
(adapter C)

input-BSF-2
(adapter A)

treated-BSF-1
(adapter A)

treated-BSF-2
(adapter B)

Figure 4.5. A wide range of reads is discarded following deduplication.
The fold change in reads before and after deduplication was plotted and normalized with
respect to reads before deduplication for each BSF Ψ-seq library.
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Adapter A Barcode Sequence

Adapter B Barcode Sequence

(1-4096)

(1-4096)

C

TCCGGC

Reads with Barcode

9e+05

6e+05

3e+05

0e+00

Adapter C Barcode Sequence
(1-4096)

Figure 4.6. Adapters display bias towards certain 6mer barcode sequences.
The distribution of barcode 6mers was graphed for adapters (A) A, (B) B, and (C) C. The
most highly overrepresented 6mer is indicated with an arrow.

I contacted Integrated DNA Technologies (IDT), who reported a known (though
unpublished) bias in the automated oligonucleotide synthesis protocol used to synthesize
these adapters. They therefore resynthesized adapter A with a new manual protocol to
ensure all 6mers were equally represented in the oligonucleotide pool. The newly
optimized adapter was utilized for the experiments carried out in the next section.
4.2.3 Optimized adapters eliminate 6mer bias, allowing effective deduplication
The IDT-optimized adapter A was utilized to prepare Ψ-seq libraries from poly(A)enriched RNA samples from BSF and PF trypanosomes in triplicate. Libraries were

64

sequenced and reads were mapped to the T. brucei genome as before. The results of this
experiment are summarized in Table 4.2. Notably, a far greater percentage of reads were
barcoded (~88%), and of these reads, a high percentage mapped to the genome. In
addition, the distribution of 6mers was far more uniform than in the previous experiment
(Figure 4.7A), which allowed for the conservation of a higher percentage of reads
following deduplication (Figure 4.7B). Satisfied that IDT adapter optimization accounted
for the biases observed in my initial pilot experiment, I moved on to a deeper Ψ-seq-like
analysis of the resulting data, detailed in the next section.

Table 4.2. Summary of results for BSF samples prepared using IDT-optimized
barcoded adapters with Ψ-seq.
Sample

Reads with
Barcode

Barcode Reads
of High Quality

Mapped to
rDNA

Mapped to
Genome

input-BSF-1

91.98%

99.83%

6.13%

83.521%

input-BSF-2

87.37%

99.82%

5.83%

84.208%

input-BSF-3

89.76%

99.75%

5.50%

82.693%

treated-BSF-1

88.23%

99.73%

4.18%

72.916%

treated-BSF-2

89.68%

99.78%

4.84%

80.369%

treated-BSF-3

84.33%

99.76%

4.93%

78.077%
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(Relative to Reads Before Deduplication)

Fold Change in Initiating Reads at a Given Position
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0.75

0.50

0.50

0.25

0.25

0.00

0.00

Before Deduplication
After Deduplication

input-BSF-1

input-BSF-2

input-BSF-3
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0e+00

input-BSF-1, Adapter A Bacrode Sequence

input-PF-1, Adapter A Bacrode Sequence
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Figure 4.7. IDT-optimized barcode adapter diversity better suited for deduplication.
(A) A higher proportion of reads are retained following deduplication of reads mapped to
the whole genome for BSF (left) and PF (right) Ψ-seq libraries. (B) The 6mer barcode
distribution for a representative BSF (left) and PF (right) library was plotted.

4.3 Ψ-seq results reveal deeper problems with high-throughput Ψ-detection
4.3.1 Detection of known sites of rRNA pseudouridylation
I first analyzed reads mapping to the rDNA locus to determine whether I could detect
known ribosomal Ψ sites detailed in [71] and [24] using the bioinformatic pipeline I built
to replicate Schwartz et al.’s Ψ-seq results (Chapter 3.1, Figure 3.2). In order to get a
more accurate sense of my false positive rate, I did not filter out hits that did not
correspond to a U in the reference genome. Because each position in the rDNA locus was
covered by over 4,096 initiating reads, I performed analysis on alignment files prior to
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deduplication to avoid collapsing reads that were not truly PCR duplicates.
Unfortunately, I failed to detect any putative Ψ sites — false positives or true positives —
in either BSF or PF trypanosomes. In addition, relative Ψ-fc peaks did not correspond to
known Ψs based on Ψ-fc plots for each rRNA, a representative example of which is
plotted in Figure 4.8.
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Figure 4.8. Known rRNA Ψs were not detected in poly(A)-enriched Ψ-seq libraries.
Ψ-fc values were plotted for the small ribosomal subunit (SSU) RNA in BSF (top) and
PF (bottom) trypanosomes. Known Ψ sites are marked by vertical red lines.
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Furthermore, each of the Ψ-detecting metrics utilized by Ψ-seq showed no
discriminatory power between true Ψ sites and false positives when applied to my data
set (Figure 4.9). The area under the Receiver Operating Characteristic (ROC) curves
(AUCs) for both the treated Ψ-ratio and the Ψ-fc were far lower than those calculated
using the published yeast Ψ-seq data set (AUC=0.544 versus AUC=0.951 and
AUC=0.442 versus AUC=0.985, respectively). I could therefore conclude that even if I
had used different cutoff values for each Ψ-detection metric, I still would not have been
able to accurately detect Ψ sites.

T. brucei rRNA

S. cerevisiae rRNA

1.00

1.00

AUC=0.985

AUC=0.951
AUC=0.544
0.75

True Positive Rate

True Positive Rate

0.75

AUC=0.442

0.50

AUC=0.559

0.25

AUC=0.562

Ψ-detection metric
Mock-treated Ψ-ratio
0.50

Treated Ψ-ratio
Ψ-fc

0.25

0.00

0.00
0.00

0.25

0.50

0.75

1.00

0.00

False Positive Rate

0.25

0.50

0.75

1.00

False Positive Rate

Figure 4.9. ROC curves demonstrate no discriminatory power in Ψ-detection
metrics in Ψ-seq libraries prepared with T. brucei poly(A)-enriched RNA.
Receiver Operating Characteristic (ROC) curves for different Ψ-calling metrics were
calculated for my trypanosome rRNA and for Schwartz et al.’s yeast rRNA. The line of
no discrimination is plotted as a dashed grey line.

While parsing through the data compiled by Schwartz et al. during my
comparative analysis, I did notice that analysis of poly(A)-enriched Ψ-seq libraries failed
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to detect several known sites of rRNA pseudouridylation. I therefore prepared libraries
from total RNA isolated only from PF parasites to again test whether I could detect
known Ψs. Ψ-seq analysis of this data, which is not shared here, once again returned
neither false nor true positive rRNA hits and produced ROC curves that indicated
virtually no discriminatory power in Ψ-detection metrics.
Because I was unable to identify Ψs by Ψ-seq analysis, I next sought to determine
whether CMC treatment was successful during library preparation. While I could not
directly assess whether CMC had successfully conjugated to Ψ targets and hydrolyzed
from non-Ψ residues, I could calculate the CMC-stat for each rRNA position (described
in Chapter 2.2.2, Equation 2.1) to see if coverage decreased around Ψs in treated versus
untreated libraries. If CMC treatment were successful, I would have observed strong
peaks in CMC-stat values around known Ψ sites, similar to those observed in Figure 2.6.
Peaks that lined up with trypanosome rRNA Ψ sites, however, were not readily
distinguishable from peaks occurring at non-Ψ positions (Figure 4.10). I also entertained
the possibility that the documented Ψ sites were not accurate, so I compared rRNA CMCstat profiles for PF libraries prepared from total RNA and from poly(A)-enriched RNA. If
I could see a consistent CMC-stat pattern, with peaks lining up across the rDNA locus,
then perhaps the reported Ψs were incorrect. However, no such pattern was observed,
leading me to conclude that CMC treatment was likely unsuccessful.
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Figure 4.10. CMC-stat analysis of trypanosome Ψ-seq libraries at the SSU locus.
CMC-stat was calculated for PF Ψ-seq libraries prepared from total RNA (top) and
poly(A)-enriched RNA (bottom). Known Ψs are indicated as red vertical lines.

The lack of experimental reproducibility — in contrast to that of the readily
reproduced Ψ-seq bioinformatic pipeline — raises concerns around the tractability of
high-throughput Ψ-detection methods. Nevertheless, I decided to proceed and apply Ψseq analysis to reads mapped to the whole genome, stopping at a number of analysis
“checkpoints” to better characterize the experimental source of failure to detect Ψ sites in
rRNA, and uncover any other caveats that might apply to Ψ-seq detection. Of course,
because CMC conjugation to Ψ — or hydrolysis from non-Ψ residues — likely did not
work, any quirks found in my Ψ-seq libraries may not apply to those prepared with
successful, Ψ-specific CMC conjugation.
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4.3.2 Detection of Ψs in the whole transcriptome
In this section, I filter candidate Ψ sites through multiple checkpoints, each of which
illuminates a caveat or flaw, either in my libraries specifically or in the published Ψdetection methods as a whole.
4.3.2.1 Putative Ψ sites are not exclusively called at reference U positions
Ψ-seq-specified cutoffs were used to call putative Ψ sites with reads aligned to the whole
genome. Because no false positives were called with these particular thresholds applied
to the rDNA locus, I was curious to know whether putative Ψs would be called at
positions that did not correspond to a reference U. Without filtering, 156 and 114 sites
were called before and after deduplication in BSF cells (73.1% hit retention), while 23
and 10 sites were called before and after deduplication in PF cells (43.5% hit retention). I
then analyzed the breakdown of reference nucleotides at each called position and found
no significant enrichment for called sites at a U, as I would expect following Ψ-specific
CMC treatment (Figure 4.11). Inefficient CMC hydrolysis from G-like residues —
including inosine resulting from A-to-I RNA editing — would have resulted in hits at
positions corresponding to a reference A, G, or U. However, positions corresponding to a
reference C were also called, which notably does not contain a CMC conjugation site so
could not be the result of inefficient CMC hydrolysis. These positions were likely not
called due to reverse transcriptional arrest mediated by secondary structure, as the Ψ-ratio
would be the same in both CMC-treated and mock-treated libraries. The called sites may
thus be the result of computational noise — sites that happened to pass the defined Ψdetection metrics — or the consequence of technical shortcomings inherent in the Ψ-seq
library preparation protocol.
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Figure 4.11. Reference nucleotide breakdown of called Ψ sites from whole-genome
deduplicated reads.

4.3.2.2 Deduplication results in newly called Ψ sites following filtering for U
I next investigated the effect of deduplication on called Ψ sites. Specifically, were new
sites called following deduplication that were otherwise obscured due to PCR duplication
events? I therefore filtered for called sites occurring at a reference U and compared sets
of putative Ψs in BSF and PF samples to determine whether deduplicated hits were
contained in the set of called sites prior to deduplication (Figure 4.12). While all
deduplicated Ψ hits fell within the set of PF hits called prior to deduplication, four new Ψ
sites were called in the deduplicated set for BSF trypanosomes. These additional sites
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might have been called due to elimination of background due to PCR duplication events.
This result should still be taken with a grain of salt given my initial low confidence that
called Ψ sites in these problematic libraries are true sites of pseudouridylation.

Procyclic Form

Bloodstream Form
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13

Before
Deduplication
(36 hits)

23

3

4

After Deduplication
(3 hits)

After
Deduplication
(27 hits)

Before Deduplication
(10 hits)

Figure 4.12. Overlap in called Ψ sites before and after deduplication.

4.3.2.3 Ψ-calling is sensitive to sequencing depth
I also observed nine times as many putative Ψ sites in BSF versus PF trypanosomes
following deduplication, which was intriguing given the increased levels of uridine
isomerization reported in BSF versus PF rRNA [24]. To make any meaningful direct
comparisons between the two life cycle stages requires equal coverage. BSF libraries,
however, were sequenced at three times the depth. I therefore sampled one-third of BSF
mapped reads and performed Ψ-seq analysis on this fraction, which returned four putative
Ψ sites (filtered by reference nucleotide). The fact that different Ψ sites may be called
following deduplication or downsampling of reads indicates just how sensitive Ψdetection is to sequencing depth. Regardless of depth or deduplication, however, BSF and
PF putative Ψ sites did not overlap (Figure 4.13).
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Figure 4.13. All called Ψ sites are life-cycle stage specific.

4.3.4 Mismatch analysis further filters putative Ψ hits
As a final checkpoint, I applied the mismatch filters described in Chapter 2.2.3 on the
final set of Ψ sites curated following U-filtering, deduplication, and appropriate
downsampling. Of the four BSF and three PF Ψ sites, three passed the appropriate
mismatch rate filters — that is, a greater than four-fold higher CMC-treated mismatch
rate (with respect to mock-treated samples) that is itself greater than 1.5%. Of those
remaining three sites, only one in the BSF candidate Ψ set — U2030 in the gene
Tb927.11.6440 — exhibited the C(/A) nonreference nucleotide incorporation profile
characteristic of Ψ (Figure 4.14). The sequence surrounding this remaining position
(GTGTTCA), however, did not map to any known H/ACA snoRNAs or guide-RNA
independent Ψ-synthases, which did not increase confidence in this putative site.
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Figure 4.14. Nonreference nucleotide incorporation profiles for putative Ψ sites
passing mismatch rate filters.

I analyzed the expression difference in Tb927.11.6440, which is annotated only as
“hypothetical protein,” between BSF and PF cells using DESeq, and found the gene is
expressed at a two-fold higher level (padj = 6.14×10-21) in BSF. The expression difference
is in line with data from a comparative RNA-seq analysis of BSF and PF transcript
expression, which was conducted in parallel with comparative ribosome profiling that
found increased ribosome occupancy on the PF transcript [119]. Counterintuitively, the
half-life of this transcript is increased in BSF versus PF trypanosomes, as indicated in
another transcriptome-wide analysis of life-cycle specific mRNA decay [35]. Considering
how Ψ factors into the relationship between transcript stability and translation efficiency
during differentiation is certainly interesting; however my low confidence in this
particular Ψ site, combined with the translated protein’s unknown function, makes
pseudouridylation to this transcript a poor subject for further study.
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Thus, from 184 candidate Ψ sites in the combined bloodstream form and
procyclic form transcriptome, I computationally winnowed my way down to only one
low-confidence Ψ-site in BSF cells that mapped to a protein of unknown function. The
initial pool of hits was likely called either due to inefficiencies in CMC conjugation and
subsequent alkaline hydrolysis, or because of computational noise that makes it
impossible to meaningfully distinguish signal from noise.
4.4 Barcoded Ψ-seq method revisited: a post-thesis defense addendum
During the defense of this thesis, a committee member raised a potential flaw in the
protocol used to generate Ψ-seq libraries with molecular barcodes. Following first strand
synthesis, the Illumina TruSeq® Stranded mRNA kit or Total RNA kit was used for
second strand synthesis and subsequent library preparation steps. With these kits, second
strand dscDNA is synthesized by first digesting the original RNA template with RNase H
to produce short fragments for priming and extension by DNA Polymerase I (Figure
4.15). The resulting dscDNA is then subjected to end repair, which digests away 5ʹ and 3ʹ
overhangs. As a result, the sequence immediately downstream of a Ψ-CMC may be lost,
so read starts may not correspond to sites of reverse transcriptional termination. In the
context of putative Ψ detection, the exact position of Ψ-CMC-mediated RT arrest may be
obfuscated when second strand synthesis priming does not occur at the exact end of the
cDNA (Figure 4.15, depicted by maroon shaded box). Loss of sequence information at
the site of RT termination may therefore have been the reason I could not accurately
detect known sites of pseudouridylation in the T. brucei ribosome.
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Figure 4.15. Schematic of second strand synthesis with Illumina TruSeq® kit.
Illumina’s TruSeq® library preparation kits perform second strand synthesis using RNase
H to digest the original RNA template into short fragments to allow for priming and
extension with DNA Polymerase I. An end repair reaction is then performed to digest
away 5ʹ and 3ʹ overhangs. As a result, the sequence just downstream of a Ψ-CMC site
may be removed prior to sequencing (depicted by maroon shaded box).

Following my thesis defense, I modified the Ψ-seq library preparation protocol to
ensure that the sequence corresponding to RT termination was included in the final
dscDNA product (Figure 4.16). CMC treatment was performed as before. Following first
strand synthesis, a 3ʹ adapter containing a randomized 6-nucleotide barcode was ligated
onto the resulting cDNA. The adapter contained a universal priming sequence, which was
used to generate the second strand using the high fidelity Phusion polymerase. Second
strand synthesis was then followed by end repair, A-tailing, and Illumina adapter ligation.
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Figure 4.16. Schematic of modified Ψ-seq library preparation.
A first strand synthesis adapter (FSS adapter) without a barcode was ligated to the 3ʹ end
of CMC-treated or mock-treated RNA. A primer (FSS primer) complementary to the
adapter was used for first strand synthesis. A second strand synthesis adapter (SSS
adapter) containing a randomized 6-nucleotide barcode was then ligated to the 3ʹ end of
the resulting cDNA and second strand synthesis was performed with a primer (SSS
primer) complementary to a universal priming sequence.

I applied this modified Ψ-seq library preparation protocol to ribosomal RNA
isolated in duplicate from bloodstream form trypanosomes to determine whether I could
now accurately detect known sites of pseudouridylation. Analysis of the resulting
sequencing reads was performed as before, except the barcode was extracted from the
‘right-hand’ read (Figure 4.3C). Once again, however, each position in the rDNA locus
was covered by over 4,096 initiating reads, so I did not deduplicate reads at the risk of
collapsing reads that were not truly PCR duplicates. Utilizing this new Ψ-seq protocol,
three Ψ sites were called, all three corresponding to known sites of pseudouridylation
(Figure 4.17, Table 4.3).
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Figure 4.17. Modified Ψ-seq protocol detects one known Ψ in the T. brucei SSU.
Ψ-fc values were plotted for the small ribosomal subunit (SSU) RNA in BSF
trypanosomes. Known Ψ sites are marked by vertical red lines. Known Ψ called by Ψ-seq
indicated by red point.

Table 4.3. Putative Ψ sites called by Ψ-seq with modified library preparation.
Gene

Position

CMC-treated Ψ-ratio

Ψ-fc

LSU5ʹ

935

0.127

3.96

LSU3ʹ

1377

0.154

3.73

SSU

1612

0.279

3.64

The results of this pilot experiment are encouraging, providing an explanation for
the high rate at which putative Ψ sites were called at positions that corresponded to a
non-U nucleotide in the reference genome, as detailed in Figure 4.11. These sites could
be the products of second strand synthesis priming further from the exact 3ʹ end of the
cDNA. As a result, they may not map exactly to the site of reverse transcriptional
termination. Nevertheless, the possibility remains that these sites were called due to
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computational noise, rather than corresponding to sites in the near vicinity of a putative
pseudouridylation target.
Furthermore, only three of 75 previously detected Ψ sites were identified, which
speaks to limitations inherent in the CMC-based Ψ detection approach. My inability to
detect the remaining Ψ sites could be due to sequencing depth, though the average
number of reads from each prepared library was ~ 1 x 107, three-fold more than the
number of reads sufficient to call known sites of pseudouridylation by Schwartz et al.
[108]. Alternatively, the failure to detect more known Ψ sites could be due to CMC
conjugation efficiency. If CMC does not efficiently conjugate to all U- and G-like
residues, there is a higher likelihood of a high false negative rate, as observed here.
Because no false positive sites were called — in other words, no sites that correspond to a
‘G’ in the reference genome — I am reasonably confident that the previous library
preparation scheme, rather than inefficient alkaline hydrolysis, was the culprit behind the
non-U reference Ψ calling detailed in Figure 4.11. The inefficiency of the method as
adapted here, combined with the caveats to Ψ detection discussed throughout the body of
this thesis, thus raises concerns that the available CMC-based Ψ-detection methods are
not robust “plug and play” methods for de novo Ψ detection.
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CHAPTER 5. Discussion
Ever tried. Ever failed. No matter. Try Again. Fail again.
Fail better.
— Samuel Beckett

5.1 Reproducibility and reusability of high-throughput Ψ-detection methods
Since I began the work detailed in this thesis, the field of pseudouridylation has grown
tremendously with reinvigorated interest in this intriguing modification. In that time,
hundreds to thousands of Ψ sites have been catalogued depending on the species
surveyed and the technique used [19,69,107]. Amidst the staggering number of novel
putative sites, however, only three — two in human rRNA and one in mRNA — have
been experimentally verified [69]. In addition, my comparative analysis of each method’s
results revealed only a small subset of Ψ sites that were reproducibly detected by two or
more approaches [131].
The aim of developing these approaches was to generate testable hypotheses as to
the functional role of pseudouridylation by identifying pseudouridylated transcripts of
biological interest. The currently available methods as they stand are not robust enough to
produce such informed hypotheses. While my comparative analysis did generate a
confident set of 10 mRNA Ψ sites in yeast, groups generating Ψ maps for new species
will not have the benefit of comparing their results to three other labs using three
different-yet-related techniques. The bioinformatic pipeline detailed by Schwartz et al. in
Ψ-seq, and later adapted for CeU-seq, is readily reproduced due to its intuitive derivation.
On the contrary, the experimental pipeline for Ψ-seq library preparation and RNA
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sequencing is not readily reused, based on my experiences in T. brucei. Following my
attempts to combine Ψ-seq with molecular barcoding, I homed in on three major areas for
improvement — apart from the absolute quantitation discussed in Chapter 3.4 — that
likely affect the low reusability I experienced.
First and foremost, for the field to move forward, a common Ψ-detection method
should be agreed upon, especially if users are to compare results with one another. CeUseq is by far the most sensitive detection method, though the commercial availability of
non-clickable CMC makes Ψ-seq a more practical option for wider use.
Second, CMC-based techniques would benefit from a quality control step to
ensure efficient CMC derivatization and alkaline hydrolysis before proceeding to library
preparation. For instance, a fluorescent biotin moiety could be conjugated to the CMCazide utilized in CeU-seq to visualize CMC conjugated to treated transcripts. This is a
very useful control step that I was developing together with the Helm group, but fell by
the wayside due to limited availability of CMCyne and publication of the other Ψdetection approaches. Of course, fluorescence could not confirm efficient hydrolysis from
non-Ψ residues. Nevertheless, quantifying some minimum standardized level of
fluorescence could create confidence that the conjugation step at least worked. To assess
efficient hydrolysis following sequencing, I propose eliminating the filter removing
putative Ψ sites at positions that do not correspond to a U in the reference genome to
assess hits resulting from unhydrolyzed G-CMC and I-CMC.
Third, deeper sequencing leads to identification of more putative Ψ sites, as
demonstrated during my attempts to profile Ψs in bloodstream form versus procyclic
form trypanosomes. In order to accurately compare putative Ψ maps, coverage must
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therefore be consistent. Consequently, I propose delineating a standardized range for
sequencing depth for each method. With that said, a cutoff threshold cannot account for
differential pseudouridylation events in response to slightly different environmental
contexts intrinsic to different laboratories or population averaging effects. Still, the closer
the field can move towards standardized experimental protocols, the more likely multiple
users are to corroborate and build confidence around a given set of pseudouridylation
events within the same biological system.
5.2 Need CMC-independent approaches for Ψ-detection
Limitations in CMC derivatization and hydrolysis efficiency, as demonstrated both in the
literature and in my Ψ-seq results with trypanosome RNA, underscore the need for high
throughput methods that circumvent CMC. Even with the modified Ψ-seq method
utilized after the defense of this thesis, only a small sampling of known ribosomal Ψ sites
were detected. The high false negative rate further highlights the limitations of CMCbased detection approaches, as they are highly reliant on CMC conjugation efficiency,
which is well-known for being temperamental. One promising method involves real-time
monitoring of the rate of nucleotide dissociation and incorporation for biological
polymerases along a single RNA or DNA molecule. The technology, known as Single
Molecule, Real Time (SMRT®) sequencing by PacBio, can identify certain nucleic acid
modifications as pauses in the polymerization machinery when the modification
interferes with base pairing at the Watson-Crick face. In the case of RNA sequencing, the
SMRT platform directly monitors the kinetics of the reverse transcription reaction,
removing the need to synthesize and amplify dscDNA. Accurate detection of methylated
deoxyribonucleotides and β-D-glucosyl-hydroxymethyluracil (base J), and of the
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modified ribonucleotide N6-methyladenosine by SMRT sequencing have been published
[38,42,123]. In addition, a patent has been filed citing successful detection of a number of
other modified nucleotides including Ψ [64]. Despite the great potential of single
molecule RNA sequencing, however, PacBio has focused on using the SMRT sequencing
technology for DNA sequencing, particularly of long (~10,000nt long) DNA reads
(personal communication).
Advances in mass spectrometry have also allowed for RNA modification mapping
of multiple RNA species at one time [74]. However, high-throughput MS has been
limited to profiling modifications in highly abundant, highly modified RNAs like tRNAs
and rRNAs. Still, mass spectrometry methods may be used to validate putative
pseudouridylation events in mRNAs as an orthogonal validation approach before
designing experiments to investigate a given Ψ site’s potential function. Additionally,
antibodies have also been raised against Ψ, which could facilitate an immunocapturebased approach similar to m6A-seq; however, these antibodies are not selective (Helm,
Motorin, and Meier, personal communication) [32]. Finally, a lesser explored approach to
Ψ detection exploits Ψ’s (and m5U’s) increased resistance to hydrazinolysis compared to
other pyrimidines [9]. Hydrazine treatment followed by aniline treatment cleaves the
polynucleotide chain at non-Ψ pyrimidines, causing termination of RT one base 3ʹ to
hydrazine-sensitive non-Ψ (i.e. U- and C-like) residues. Thus, this approach is the direct
complement of the CMC/RT approach, though experimental caveats have been
investigated to a far lesser degree.
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5.3 Policy reforms to incentivize collaboration, corroboration, and revision
Science not published is often regarded as science not done. By this standard, a large
fraction of replication studies or research that results in negative or non-confirmatory data
has never come to pass because it is not widely accessible by the scientific community.
Modern day mainstream scientific publishing, however, screens for articles based on
perceived importance and impact, which often biases publication towards studies that
report novel and positive results [36]. There is also an implied judgment on studies that
fail to replicate or result in negative data — namely, that they were conducted by a set of
sloppy scientists. Interpersonal politics and etiquette within the culture of science may
thus further disincentivize entering the results of post-publication peer review into the
public record. This mentality can also foster an unwillingness to transparently share data,
lest inconsistencies or overlooked caveats be uncovered.
Nevertheless, science proceeds by collaboration, corroboration, and revision.
Research of the sort undertaken in this thesis is therefore crucial to correct or improve
upon the scientific record. Technological advances of the day — particularly the
increased capacity of servers to efficiently store and share information — have allowed
for policy innovations that incentivize transparency, replication, and publication of data
of all sorts. In this section, I discuss some of these policies, which collectively form the
basis of the open science movement, and how they relate to my own experiences
comparing published data, attempting to replicate a published technique, and seeking an
accessible platform for publication of the results.
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5.3.1 Incentivizing transparency
To conduct my comparative analysis, I had to parse through data generated by four
different groups. Raw sequencing reads were readily accessible, owing in large part to
data-sharing requirements. Since 2008, the National Institutes of Health (NIH) has
required that funded projects share relevant data within one year of publication [86]. U.S.
government funding agencies like the National Science Foundation (NSF) and the
Centers for Disease Control (CDC) have since followed suit, particularly under further
incentive by a 2013 memo from the White House Office of Science and Technology
Policy (OSTP) on increasing public access [51]. Similar policies have swept the field,
implemented by governmental organizations outside the U.S. like CERN and charitable
foundations like the Bill & Melinda Gates Foundation. The Transparency and Openness
Promotion (TOP) Committee, organized by the Center for Open Science, Science
Magazine, and the Berkeley Initiative for Transparency in Social Science, has also
generated a series of guidelines for best practices in transparent publication, which is
under review by over 500 journals [2,94].
Top-down mandates to submit data used in publication, however, ignore
inconclusive data sets like the ones generated during my Ψ-seq experiments in T. brucei.
It could well be that my data sets are just one in a sea of several failed Ψ-seq experiments
that could collectively highlight compelling flaws in and caveats to Ψ detection. As a
result, scientific fields as a whole have little opportunity to learn from collaborative
analysis of negative data. Publication of this brand of data thus requires bottom-up
cultural shifts that view negative data as an equal contribution to scientific practice [87].
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Even with confirmatory data flooding repositories, there is still a need to integrate
data-processing workflows so that they are likewise open for use and inspection. For
instance, while I was able to easily access raw reads through their Gene Expression
Omnibus (GEO) Accession Numbers, the scripts utilized to process the data were not
openly accessible. I was therefore left to replicate the pipelines based on each technique’s
Methods section. In fact, I chose Ψ-seq’s pipeline in large part because I could not
replicate Pseudo-seq’s computational approach even on the authors’ own data.
Independent platforms, like the Open Science Framework (OSF), now exist to
easily and transparently link workflow to data. For instance, the OSF allows researchers
to store and selectively share every step of their work, allowing both data and pipelines
used for analysis to be shared even before publication. Utilizing these platforms for nextgeneration sequencing studies can increase the robustness of data analysis, allowing
research stakeholders to collaboratively, for instance, catch coding errors or debate the
use of certain statistical tests. In so doing, data analysis pipelines may become more
standardized so as to be reused by multiple groups, instead of existing as standalone
computational methods associated with only one or a few publications that then need to
be re-derived on an ad hoc basis. Adoption of frameworks like the OSF therefore has the
potential to reduce competition and foster communal collaboration in an ongoing peer
review process even after publication.
5.3.2 Incentivizing replication studies
Transparent data and analysis sharing are often posed as solutions to a broader
conversation centered on reproducibility of results. A poll conducted by Nature and
published in May 2016 reports that of 1,500 scientists surveyed, 90% believe there is a

87

slight to significant crisis around reproducibility [5]. In fact, most of the scientists
surveyed had tried and failed to replicate either their own or someone else’s experiments.
The so-called “reproducibility crisis” originally gained mainstream attention in 2012
following the finding that many preclinical research studies could not be reproduced [15].
In 2015, reproducibility hit the media radar once again, eliciting coverage from the likes
of The Atlantic, Vox.com, and The New York Times, following the completion of The
Reproducibility Project: Psychology in August 2015 [95]. A collaboration of 270
researchers undertook the replication of 100 studies published in three psychology
journals, where the data were openly accessed. The rationale was that potentially
problematic practices — “selective reporting, selective analysis, and insufficient
specification of the conditions necessary or sufficient to obtain the results” — might bias
results so that they appear statistically significant, while an alternative, more objective
third party analysis may show otherwise.
97% of the studies originally reported statistically significant results, while only
about a third of the replications were able to corroborate those results. These findings
sparked controversy as to the validity of the methodology of the replication studies in
which each side essentially accused the other of not understanding statistics [4,45]. The
debate itself, which took place in Science, demonstrated that research is often open to
interpretation and that the more points of view we have addressing a given problem, the
more opportunities for productive conversation around methodology and results.
While psychology is often dismissed as not a “hard science,” the Reproducibility
Project: Cancer Biology is currently under way, which may reveal similar obstacles to
replication in a “harder” science. Researchers are attempting to independently replicate
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37 high-impact experimental results in preclinical cancer biology studies published
between 2010 and 2012 [34]. The project notably scaled back from replicating 50 studies
due to budgetary constraints, which highlights a lack of support for replication studies
even in a field like cancer biology where false leads can translate to tremendous time and
resources wasted on clinical trials.
Next-generation sequencing (NGS) analysis, however, is rather inexpensive by
comparison, only requiring a computer, coding skills, and time.3 My comparative
analysis of the replicability of putative Ψ sites using different NGS Ψ-detection
techniques required only an investment in time. I was therefore curious to track
reproducibility efforts undertaken with NGS sequencing data, apart from my own. As a
crude first approximation, I searched for articles containing the phrase “next generation
sequencing” with or without the term “reproducible” or “reproducibility” in the title or
abstract on pubmed.gov. While articles containing “next generation sequencing” have
gone up tremendously since the advent of NGS technologies, articles with “reproducible”
or “reproducibility” have remained consistently low by comparison (Figure 5.1). As
biology continues to generate big data, efforts to at the very least replicate analyses are
crucial to ensuring that fields are pursuing true biological leads that result from robust
data generation and analysis methods.

3

As an aside, I could imagine undergraduate students replicating NGS analysis on openly
accessed data as part of an advanced curriculum or thesis project, combining an
educational opportunity with an inexpensive and valuable contribution to the scientific
community.
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Figure 5.1. Pubmed.gov search terms since the advent of NGS technologies.

5.3.3 Incentivizing alternatives to traditional journal publication
Even without budgetary restrictions, there is little incentive to replicate results,
particularly for early stage scientists like myself, who must innovate in order to move up
the career ladder. We are more susceptible to the “publish or perish” mantra — the very
same mantra that can pressure publication of irreproducible results in the first place —
because a long list of publications on a resume is a conspicuous indicator of merit. In
fact, my comparative analysis of high-throughput Ψ-detection methods was incentivized,
in part, by a publication opportunity. Specifically, I was invited to write a “critical”
review of the currently available methods as an objective fifth party. The results of my Ψseq experiments with T. brucei, however, do not readily fit into the traditional publishing
structures, as they are neither innovative nor novel. Rather, they are inconclusive findings
that could nevertheless benefit from peer review and open comment.
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Fortunately, norms around publishing are evolving to fill the need for more
transparent reporting and replication studies. Open-access journals like the Journal of
Negative Results in BioMedicine (BioMed Central) and F1000Research provide a peerreviewed platform for studies that can, for instance, prevent fellow researchers from
pursuing false leads and generate collaborative discussions on how to improve existing
techniques. In addition, preprint servers allow for direct uploading of complete scientific
manuscripts not subjected to traditional peer review, which are accessible by the public.
Paper preprints were introduced in the 1960s, while electronic preprints were first
introduced in 1991 with arXiv, founded by Paul Ginsparg for rapid communication of
scientific findings in physics, mathematics, computer science, quantitative biology,
quantitative finance, and statistics. ArXiv has become embedded in the culture of these
fields, which enjoy submissions of over 100,000 papers to the server each year. Preprints
are currently used minimally in the life sciences — where the preprint server of choice is
bioRxiv — perhaps owing to a cultural reluctance to share results before they have gone
through the quality check of peer review. Results in the biomedical sciences also have the
potential to be commercialized, creating another obstacle to sharing proprietary findings
or techniques. The onus of establishing quality is therefore left to the reader of the
preprint, as opposed to a review board established by the journal. Proponents of preprints
counter with the benefits of democratizing and de-anonymizing peer review through
bioRxiv’s comments section. Preprints have the added benefit of establishing priority in
discoveries when publishing positive results, and many journals now accept manuscripts
previously shared on a preprint servers [17].
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5.5 Concluding remarks
The work presented in this thesis highlights not only limitations in high-throughput
approaches to Ψ-detection, but also cultural limitations in the way that negative or nonconfirmatory results can be broadly shared with the scientific community. As science
continues to move more towards the generation and analysis of big data, there is great
merit in detailed attention to techniques that are not readily reused and to results that are
not replicated. In line with the tenets of the open science movement, I plan to assemble a
condensed but thorough version of the work detailed in Chapter 4 for preprint
publication. I will also deposit my data into PubMed Central and experiment with
platforms like the Open Science Framework to share my workflow for comment and
reuse. My transcriptome-wide hunt for uncharted sites of pseudouridylation has
demonstrated that even work that results in experimental failure can be a valuable
contribution to the practice and products of scientific inquiry.
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CHAPTER 6. A thesis condensed for nonscientists4
Knowledge is a big subject. Ignorance is bigger. And it is
more interesting.
—Stuart Firestein, Ignorance: How it Drives Science

Ever tried. Ever failed. No matter. Try again. Fail again.
Fail better.
—Samuel Beckett in Failure: Why Science Is So Successful

My first week in the lab, my boss plopped a book with the bold title Ignorance: How it
Drives Science. And now, as I wrap up writing my dissertation, she has given me its
sequel, Failure: Why Science Is So Successful. Preternatural optimist that she is, she did
not gift these books out of pessimism or wry passive aggression. Rather, she believed
they contained important lessons. Lessons that perfectly bookend my Ph.D. career.
My time in the lab began with ignorance — not the wide-eyed, first-year graduate
student variety, but the rigorous brand that embraces an open question. A great
conundrum in modern biology is how life’s great diversity stems from four letters — A,
C, G, and T — arranged in a near-infinite array to compose life’s blueprint molecule:
DNA. Now, consider that every cell in your body contains the exact same complement of
DNA. Yet a heart cell looks and acts completely different from a brain cell which looks
and acts completely different from a skin cell. So how did a heart cell, a brain cell, and a
4

This chapter will be submitted to Scientific American blogs for publication. Underlined
portions correspond to hyperlinks in the text.
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skin cell arrive at such different biological fates when given the exact same set of
molecular blueprints?
To deploy the blueprint’s directions, instructions must first be transcribed to an
intermediate molecule — the RNA — which then delivers them to the cellular machinery
for execution. So understanding the dynamics of RNA, smack at the front lines of cellular
activity, can help us understand how diversity emerges from the same DNA blueprint.
RNA is similarly composed of a four-letter alphabet: A, C, G, and U. That
alphabet can be expanded upon with a library of over 100 chemical tweaks to fine-tune
RNA function — a small M added to an A or a chemical S to a U. Of these alphabetical
adornments, one stands out as the most ubiquitous: a subtle structural change in the
genetic letter U to a pseudo-U, or pseudouridine (Ψ). Here, ignorance comes to play.
While Ψ was first discovered in the 1950s, we still don’t know much about its
precise biological function today, except that without Ψ, cells die. We do, however, have
some clues — one that particularly piqued my interest. Introducing Ψs into a set of
instructions that dictate how a protein is made changed the way those instructions were
interpreted by the cell. Ψ unexpectedly recoded RNA’s message beyond the mandates of
the genetic code — a code considered fully cracked in the 1960s.
So in Ψ, I found a candidate for how diversity arises from DNA’s hard-coded
instructions. But that study was undertaken in an artificial system, which left open the
question: where does Ψ naturally lie? By understanding where Ψs are, we might begin to
uncover what exactly they do to affect how cells behave. When I wound my way to this
question, we still had no methods to map Ψs beyond a few varieties of RNA. So, with the
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power of next-generation sequencing technologies that first emerged to map the human
genome, I went Ψ-hunting.
Meanwhile, the allure of Ψ had entered into the zeitgeist, calling researchers from
around the world to endeavor on the same Ψ-charting quest. I was beat to the punch when
four methods — three of which were released back-to-back-to-back — were published
spotting Ψs in a whole host of RNAs. I decided to make the best of being quadruply beat
to the punch and compared each group’s Ψ maps, partly out of curiosity, but mostly
because I was asked to review the techniques as an objective fifth party. All four methods
were based on the same principle, so their results should overlap well with one another.
But they did not. And here enters failure.
Of the hundreds to thousands of Ψs catalogued by each method, only a small
fraction of sites were found by them all. I was genuinely surprised by the result. So I
hunkered down and thought through a host of technical and biological caveats that were
not detailed in the original publications. I then tried to apply one of those methods to map
Ψs in African trypanosomes, the single-celled parasites that cause African sleeping
sickness. But, try as I might, I could not get the method to work. And so, more failure.
Failure is the natural product of risk, and there’s nothing riskier than the pursuit of
ignorance — asking those big bold questions that probe the unknown. But while the
practice of science is riddled with failures — from the banal failures of day-to-day life at
the bench to the heroic, paradigm shifting failures that populate the book called Failure
— many scientists are uncomfortable with the idea. We publish our innovations, the
stories of how our ignorance led to success. Where the “publish or perish” mantra
prevails, these stories are essential to making a name for ourselves and securing grant
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money. So there is little incentive to replicate the work of others or report experimental
failure. In fact, there is barely a medium to publish these sorts of efforts, which are
relegated to the bottom of the file drawer.
But the scientific method hinges on self-correction, which requires transparent
reporting of positive (or negative) data and corroboration (or contradiction) of previous
experiments. And so I wanted to share my work, to open it up to comment, to transform
my failure into something productive. If I couldn’t get these Ψ mapping methods to work
in my hands, that’s a problem worth sharing because chances are, I’m not alone. This is
how we avoid chasing false leads, how we improve our practices, how we move science
forward. These tenets lie at the heart of the “open science” movement, which I have come
to embrace (despite its New-Agey name) as I have ventured to share the failed fruits of
my doctoral work.
Of course, open science is easier said than done. The increasing competitiveness
of certain scientific fields has disincentivized transparency and collaboration. There is
also a value judgment that comes with sharing experimental failure — a vulnerability that
your peers will view your efforts as sloppy, rather than earnest and honest. So distributing
negative or non-confirmatory data comes with an extra burden of proof.
Still, policy reforms and open science advocates are working to incentivize
practices that foster open collaboration. Open-source software like the Open Science
Framework now exist for collaborative sharing of data and data-processing workflows.
Peer-reviewed publications like F1000Research are now accepting negative or nonconfirmatory data of the sort I generated during my thesis. Preprint servers — which
allow for direct uploading of complete manuscripts without formal peer review (but open
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for comment) and have long been embraced by the physics community — are now
gaining steam in the life sciences thanks to the work of advocacy groups like ASAPbio.
While I haven’t uncovered any mysteries in the world of RNA biology, I have
learned that science needs to fail better. I am now conducting further investigation into
the source of my failures with the hopes of finding and publishing their root so it may be
of use to all those Ψ chasers. Because in science, things often don’t work out the way we
think they should, and we are left with our ignorance. But the narratives we form around
failure — transparently, openly, and together — can be just as valuable as those we form
around success.
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CHAPTER 7. Materials and methods
7.1 Culture methods and strains
74-D694 (SY670) yeast cells, courtesy of the Serio laboratory at the University of
Arizona, were used for CMC-seq pilot experiments. Yeast were grown to log phase
(OD600 ≈ 1.0) at 30˚C in YPD media (Sigma-Aldrich).
T. brucei bloodstream form cells used were cultured from the strain Lister 427
(antigenic type MITat1.2 clone 221a) in HMI-9 media at 37˚C. Procyclic form Lister 427
cells were grown in SDM-79 media at 30˚C.
7.2 CMCyne derivatization and “click” chemistry
15 pmol of in vitro transcribed tRNATyr were suspended either in 47 mM CMCyne in
BEU buffer (7 M urea, 4 mM EDTA at pH 8.5, 50 mM bicine) or in BEU buffer alone for
a 10 µL total reaction volume. Samples were incubated for 2 hours at 37˚C and were then
subject to ethanol precipitation. CMCyne-treated or mock-treated samples were then
resuspended in hydrolysis buffer (50 mM (NH4)2CO3, 2 mM EDTA) at pH 10.5, 11.0, or
11.5, and incubated at either 37˚C or 42˚C for either 2.5 or 3 hours. Following hydrolysis,
RNA was again ethanol precipitated and subjected to “click” chemistry with the
fluorescent azide atto488. Atto488-azide was conjugated to tRNATyr in a 20 µL reaction
with 2.5 mM TPTA, 5 mM sodium ascorbate, 0.5 mM CuSO4•5H2O, and 0.05 mM
atto488-azide. The light-protected reaction proceeded at 21˚C for 2 hours, shaking at 350
rpm. RNA was precipitated a final time and resuspended in water before being run on a
15% SDS-PAGE gel. The gel was scanned first for fluorescence, then stained with
GelRed and scanned for RNA integrity. For the 30mer Ψ-containing oligonucleotide (or
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its U-containing counterpart), CMC treatment and atto488 conjugation proceeded as
detailed above, except 30 pmol of the RNA oligonucleotide were used to start.
7.3 Generation of sequencing libraries
7.3.1 CMC-seq library preparation
Yeast cells were harvested by centrifugation and total RNA was extracted using the
MasterPure™ Yeast RNA Purification Kit by Epicentre, which included a DNase
treatment step. For each replicate, 12 µg of total RNA was either suspended in 0.17 M
CMC (Sigma 29469, ≥99.0%, now discontinued) in BEU buffer (treated) or in BEU
buffer alone (mock-treated), and incubated for 2 hours at 37˚C. The reaction was stopped
by ethanol precipitating RNA. The pellet was resuspended in 50 µL of hydrolysis buffer
at pH 11.0 and the mixture was incubated for 2.5 hours at 37˚C. RNA was again
precipitated. Libraries were prepared with the TruSeq® Stranded Total RNA kit
(Illumina) without the RiboZero Deplete and Fragment RNA step in the protocol. The
resulting dscDNA libraries were then diluted to 15 nM and pooled for sequencing on the
Illumina HiSeq 2000 for single-end 100bp reads.
7.3.2 Ψ-seq library preparation with molecular barcodes
Trypanosome cells were harvested by centrifugation and total RNA was extracted using
RNA STAT-60 (Tel-Test, Inc.), according to the manufacturer’s protocol. For poly(A)enriched libraries, 300 µg of total RNA was used as starting material per replicate,
followed by poly(A) enrichment using the µMACS mRNA Isolation Kit for total RNA.
RNA was then DNase treated using RQ1 RNase-Free DNase (Promega) and cleaned with
2x RNAClean® XP beads (Agencourt), yielding approximately 1-3 µg of starting material
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for CMC treatment. For libraries prepared from total RNA, 12 µg of RNA (following
DNase digestion and clean-up) was used as starting material per replicate.
Prior to CMC derivatization, RNA was fragmented for 15 minutes with RNA
fragmentation reagent and stop solution (Ambion), according to the manufacturer’s
specifications, and cleaned with 2.5x RNAClean® XP beads. CMC treatment and
hydrolysis proceeded as in 7.3.1, except that RNA was cleaned with 3x RNAClean® XP
beads following alkaline hydrolysis. In addition, CMC at ≥99.0% purity was
discontinued, so I had to use CMC at ≥95% purity from Sigma.
RNA was then dephosphorylated with FastAP Thermosensitive Alkaline
Phosphatase (Thermo Scientific), cleaned with 3x RNAClean® XP beads, followed by
overnight 3ʹ adapter ligation with T4 RNA ligase (New England Biolabs) at 16˚C. After
cleaning RNA once again with 3x RNAClean® XP beads, first strand synthesis primers
with 5ʹ 2N, 1N, or 0N ends were mixed at equimolar concentrations and used for first
strand synthesis with Superscript III Reverse Transcriptase (Invitrogen). I then proceeded
to library preparation with the TruSeq® Stranded mRNA kit (Illumina), starting at the
second strand synthesis step. The only deviation from the manufacturer’s protocol was
that dscDNA was cleaned with 3x AMPure XP beads (Agencourt) following second
strand synthesis. The resulting libraries were diluted to 15 nM and pooled for sequencing
on the Illumina HiSeq 2500 for 50bp paired-end reads with 10% spike-in of PhiX
Sequencing Control (Illumina) to ensure accurate cluster calling.
7.3.3 Ψ-seq library preparation with molecular barcodes modified
Total RNA was extracted from bloodstream form trypanosome cells harvested as in 7.3.2.
For each library, 12 µg of total RNA (following DNase digestion and clean-up) was used
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as starting material per replicate. This time, however, RNA was not fragmented prior to
CMC treatment and hydrolysis, which proceeded as in 7.3.2.
RNA was dephosphorylated with FastAP Thermosensitive Alkaline Phosphatase,
cleaned with 2.5x RNAClean® XP beads. Overnight 3ʹ adapter ligation with T4 RNA
ligase at 16˚C followed, this time with a short adapter that lacked a barcode. The RNA
was cleaned once again with 2.5x RNAClean® XP beads. First strand synthesis was
performed with Superscript III and first strand synthesis primers with 5ʹ 2N, 1N, or 0N
ends mixed at a 4:2:1 molar ratio. The resulting cDNA was cleaned with 2.5x AMPure
XP beads, followed by dephosphorylation with FastAP Thermosensitive Alkaline
Phosphatase, and cleaned again with 2.5x AMPure XP beads. The sample was subjected
to overnight 3ʹ adapter ligation with T4 RNA ligase at 16˚C with a DNA oligonucleotide
that contained a randomized six-nucleotide barcode and a universal priming sequence.
The oligonucleotides used for this experiment are preceded by ‘mod Ψ-seq’ in Table 7.1.
The reaction was cleaned with 2.5x AMPure XP beads and subjected to second
strand synthesis with Phusion High-Fidelity DNA Polymerase (Thermo Fisher
Scientific). Second strand synthesis primers with 5ʹ 2N, 1N, or 0N ends were mixed at a
4:2:1 molar ratio. To ensure a stranded cDNA library, I utilized an oligonucleotide
mixture at a final concentration of 200 µM dATP, dCTP, and dGTP and 400 µM dUTP.
The resulting dscDNA product was cleaned with 2.5x AMPure XP beads, followed by
end repair using the NEBNext® End Repair Module. I then proceeded to library
preparation with the TruSeq® Stranded mRNA kit (Illumina), starting at the A-tailing
step. The resulting libraries were diluted to 10 nM and pooled for sequencing on the
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Illumina HiSeq 2500 for 100bp paired-end reads with 10% spike-in of PhiX Sequencing
Control (Illumina) to ensure accurate cluster calling.
7.4 Sequencing data analysis
7.4.1 CMC-seq analysis
Illumina sequencing adapters were trimmed and low-quality reads were removed using
trim_galore(v0.3.7) powered by Cutadapt [82]. The remaining reads were aligned to the
rDNA locus of the yeast genome (sacCer3; locus: chrXII:451000..459999) using
bowtie(v1.1.1) allowing only uniquely mapping reads with no more than two mismatches
per read (-v 2 -m 1) [67]. Per-base coverage was then calculated using bedtools(v.2.20.1)
multicov, which was then normalized using DESeq(v1.20.0) in Bioconductor for R [99].
CMC-stat was derived by first calculating the median normalized coverage at
each position for treated and mock-treated libraries. The log2-transformed ratio of mocktreated coverage to treated coverage was calculated, adding a pseudocount of 1 to both
the numerator and the denominator to avoid division by 0. CMC-stat plots were generated
using the R package ggplot2(v.2.1.0).
For mismatch analysis alignment files were parsed using the Python module
pysam(v.0.8.1) to determine the frequency of nonreference nucleotide incorporation at
each position and the total number of reads mapping to each position. A mismatch rate
(MR) was calculated by dividing the number of mismatched reads by the total number of
reads at each position. The median MR was then calculated for treated and mock-treated
libraries and the log2-transformed ratio of treated to mock-treated median MRs was
determined. Further analysis of nonreference nucleotide incorporation profiles was
restricted to positions with a median treated MR of greater than 1.5% and a log2102

transformed MR ratio of greater than 2. Nonreference nucleotide incorporation profiles
were determined by dividing the number of each nonreference nucleotide incorporated at
a given position by the total number of reads covering that position. Ternary plots were
then drawn with the ggplot2 extension ggtern(v.2.1.4) in R.
7.4.2 Ψ-seq analysis
The Unix command grep was utilized to extract ‘left-hand’ reads containing the last eight
nucleotides of the common priming sequence, followed by six random nucleotides and
the ligation linker (i.e. GCGTTCGT……ACAG for adapter A). One mismatch was
allowed within the adapter sequence. The SeqIO module from BioPython(v.1.63) was
used to extract barcode sequences to create an index file with read name and barcode
sequence used later for deduplication. The adapter sequence was then trimmed from the
remaining left-hand reads, and corresponding paired ‘right-hand’ reads were extracted.
Right-hand reads were first aligned to the rDNA locus (genome Tb927v5.1;
genes: Tb927.2.1389, Tb927.2.1398, Tb927.2.1407, Tb927.2.1416, Tb927.2.1425,
Tb927.2.1434, Tb927.2.1443, Tb927.2.1452) using bowtie2(v.2.1.0) in end-to-end
alignment mode [66]. Reads unaligned to the rDNA locus were then aligned to the whole
genome. A custom R script utilizing the ‘data.table’ package was then used to
deduplicate reads by discarding copies of those that map to the same position with the
same sequence and barcode.
Following deduplication, the Python module pysam was used to calculate the
number of reads initiating at a given position, the total number of reads covering that
position, and the number of nonreference nucleotides incorporated for every mapped
position. For each replicate, the Ψ-ratio was calculated for every position by dividing the
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number of read starts by the total number of reads covering a given position, adding a
pseudocount of 1 to both the numerator and denominator to avoid division by 0. The Ψ-fc
was then calculated for every position by log2-transforming the ratio of the median Ψratio for treated libraries to the median Ψ-ratio for mock-treated libraries. Only positions
covered by all replicates were considered. Putative Ψ sites were called for positions 5ʹ to
a position with a treated Ψ-ratio greater than 0.1 and a Ψ-fc greater than 3.
Ψ-fc plots were generated using the R package ggplot2. Receiver operating
characteristic (ROC) curves were generated for rDNA Ψ-ratio and Ψ-fc values using
ggplot2 with extension plotROC(v.2.0.1).
7.4.3 Modified Ψ-seq analysis
Analysis was similar to that detailed in 7.4.2, except that the Unix command grep was
utilized to extract ‘right-hand’ reads containing the last eight nucleotides of the common
priming sequence, followed by six random nucleotides and the ligation linker. The SeqIO
module from BioPython(v.1.63) was used to extract barcode sequences to create an index
file and then to trim adapters from the FASTQ reads. 100bp sequencing was utilized, and
several reads corresponded to cDNA fragments less than 100bp in size. Consequently,
adapters were trimmed from both ends of the reads, and only the right-hand reads were
used for alignment. Reads were aligned to the rDNA locus using bowtie1(v1.1.1)
allowing only uniquely mapping reads with no more than two mismatches per read (-v 2 M 1). The resulting alignment files were analyzed as in 7.4.2.
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7.5 Primer sequences
Table 7.1. Primer sequences.
Sequence (5ʹ → 3ʹ)

Name
tRNA

Tyr

oligo

TGG TGG TGG GGG AAG GAT TCG AAC CTT CGA AGT CTG TGA CGG
CAG ATT TAC AGT CTG CTC CCT TTG GCC GCT CGG GAA CCC CAC C

Ψ-seq Adapter A /5Phos/ CUG UNN NNN NAC GAA CGC AAU CAG CUU GCC G/3ddC/
Ψ-seq Adapter B /5Phos/ CUG UNN NNN NGU CAG GAU CAG GAG GCC GU G/3ddC/
Ψ-seq Adapter C /5Phos/ CUG UNN NNN NCG ACG CCG GAU UAC GGG A G/3ddC/
FSS-A-2N

NNG GCA AGC TGA TTG CGT TCG T

FSS-A-1N

NGG CAA GCT GAT TGC GTT CGT

FSS-A

GGC AAG CTG ATT GCG TTC GT

FSS-B-2N

NNA CGG CCT CCT GAT CCT GAC

FSS-B-1N

NAC GGC CTC CTG ATC CTG AC

FSS-B

ACG GCC TCC TGA TCC TGA C

FSS-C-2N

NNT CCC GTA ATC CGG CGT CG

FSS-C-1N

NTC CCG TAA TCC GGC GTC G

FSS-C

TCC CGT AAT CCG GCG TCG

mod-Ψ-seq FSS

/5Phos/ GUC UAU CGU CCG GAG /3ddC/

mod-FSS-2N

NNC TNC GGA CGA TAG AC

mod-FSS-1N

NCT NCG GAC GAT AGA C

mod-FSS-0N

CTN CGG ACG ATA GAC

mod-Ψ-seq SSS

/5Phos/ CUG UNN NNN NAC GAA CGC AAT CNN GG /3ddC/

mod-SSS-2N

NNC AGC GAT TGC GTT CGT

mod-SSS-1N

NCA GCG ATT GCG TTC GT

mod-SSS-0N

CAG CGA TTG CGT TCG T
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